US11241179B2 - Method of monitoring health status of a patient - Google Patents

Method of monitoring health status of a patient Download PDF

Info

Publication number
US11241179B2
US11241179B2 US15/063,377 US201615063377A US11241179B2 US 11241179 B2 US11241179 B2 US 11241179B2 US 201615063377 A US201615063377 A US 201615063377A US 11241179 B2 US11241179 B2 US 11241179B2
Authority
US
United States
Prior art keywords
pressure
patient
catheter
data
sensing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US15/063,377
Other versions
US20170100561A1 (en
Inventor
Daniel R. BURNETT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TheraNova LLC
Original Assignee
TheraNova LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TheraNova LLC filed Critical TheraNova LLC
Priority to US15/063,377 priority Critical patent/US11241179B2/en
Assigned to THERANOVA, LLC reassignment THERANOVA, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BURNETT, DANIEL R.
Publication of US20170100561A1 publication Critical patent/US20170100561A1/en
Priority to US17/547,040 priority patent/US11963773B2/en
Application granted granted Critical
Publication of US11241179B2 publication Critical patent/US11241179B2/en
Priority to US18/610,847 priority patent/US20240215884A1/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/20Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • A61B5/202Assessing bladder functions, e.g. incontinence assessment
    • A61B5/205Determining bladder or urethral pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/0215Measuring pressure in heart or blood vessels by means inserted into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1112Global tracking of patients, e.g. by using GPS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/16Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/20Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • A61B5/207Sensing devices adapted to collect urine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/389Electromyography [EMG]
    • A61B5/392Detecting gastrointestinal contractions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852Catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852Catheters
    • A61B5/6853Catheters with a balloon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7278Artificial waveform generation or derivation, e.g. synthesising signals from measured signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0017Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02Holding devices, e.g. on the body
    • A61M25/04Holding devices, e.g. on the body in the body, e.g. expansible
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045Devices for taking samples of body liquids
    • A61B10/007Devices for taking samples of body liquids for taking urine samples
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0247Pressure sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0261Measuring blood flow using optical means, e.g. infrared light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/029Measuring or recording blood output from the heart, e.g. minute volume
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/0816Measuring devices for examining respiratory frequency
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/369Electroencephalography [EEG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M2025/0001Catheters; Hollow probes for pressure measurement
    • A61M2025/0003Catheters; Hollow probes for pressure measurement having an additional lumen transmitting fluid pressure to the outside for measurement

Definitions

  • the disclosed technology relates to the field of medical devices, in particular devices capable of sensing physiologic data based on sensors incorporated into a catheter adapted to reside in the a urinary tract of a patient.
  • the Foley catheter named for Dr. Frederick Foley who first described a self-retaining balloon catheter in 1929, has been in use since the 1930's, in a form nearly identical to its early models.
  • a Foley catheter has a proximal portion that remains outside the body, a length that traverses the urethra, and a distal end that resides in the urinary bladder.
  • the Foley catheter is held in place by an inflatable balloon that stabilizes the device in place, and prevents inadvertent withdrawal from the bladder.
  • a typical Foley catheter includes at least two lumens along its length; one lumnen serves as a conduit that drains the bladder, and the second lhunmen serves as an air conduit that allows the balloon to be controllably inflated and deflated.
  • the Foley catheter widespread in use, having a low cost, and easily put in place by health care professionals may offer still further opportunity as a vehicle for deriving critical diagnostic information.
  • the technology disclosed herein provides for the delivery of highly resolved and previously unavailable diagnostic information, as may be derived from a Foley catheter with pressure sensing capability.
  • the disclosed technology relates to a Foley type catheter for sensing physiologic data from the urinary tract of a patient, the physiologic data particularly including those gathered by high fidelity pressure sensing and transduction into signals suitable for processing.
  • the pressure-sensing Foley type catheter may further be enabled to sense temperature and analytes of clinical significance.
  • the fluid within the fluid column may include a gas, such as air or carbon dioxide, or it may include a liquid.
  • a gas such as air or carbon dioxide
  • a liquid such liquid may include urine, as sourced from the bladder.
  • the pressure interface may include an elastic membrane or a substantially inelastic membrane.
  • the pressure interface is substantially homogeneous across its surface area.
  • the pressure interface can be heterogeneous, having regions that vary in composition or thickness, or having features that provide an elasticity bias.
  • the pressure interface includes an expandable balloon.
  • an expandable balloon may include either an elastic membrane or a substantially inelastic membrane.
  • Embodiments of the balloon, particularly those having an inelastic membrane, upon expansion, the balloon has a volume in the range of about 0.1 cc to about 2 cc.
  • Other embodiments of the balloon, upon expansion, may have larger volumes, for example, in a range of about 2 cc to about 5 cc, or in a range of about 5 cc to about 250 cc, a volume that is greater than 250 cc.
  • embodiments of the balloon upon inflation, may have a diameter that ranges between about 6 mm and 8 mm.
  • the pressure interface includes a membrane arranged across an opening.
  • the membrane is sufficiently elastic to respond to an internal-external pressure differential across its surface.
  • the Foley type catheter further includes one or more analyte sensors.
  • Analyte sensors included in the scope of the disclosed technology include sensors for analytes of any clinical significance.
  • such analytes may include any analyte selected from a group including pH, a gas, an electrolyte, a metabolic substrate, a metabolite, an enzyme, or a hormone.
  • such analyte sensor may be able to sense any of a metabolic substrate or a metabolite, the analytes may include glucose or lactic acid.
  • the analyte may include cortisol.
  • the Foley type catheter further includes one or more electrodes arranged as electrical activity sensors.
  • electrical activity sensors may deliver physiologic data that can be transformed to yield an electrocardiogram (EKG) or an electrogastrogram (EGG).
  • the Foley type catheter further includes a light source and a light sensor, the sensor configured to capture light emitted from the light source.
  • the light source and the light sensor may be configured to operate as a pulse oximeter, the light sensor being able to deliver a signal that can be transduced into a pulse rate.
  • the light source and the light sensor may be configured to operate as an analyte sensor.
  • the Foley type catheter may further include an expandable pressure-delivery balloon disposed on the catheter so as, upon expansion, to contact a wall of the bladder or the urethra; and a light source and a light sensor disposed proximate the tissue-compressing balloon.
  • the pressure delivery balloon, the light source, and the light sensor may be arranged such that when the expandable pressure balloon is expanded so as to blanche a tissue surrounding it as detected by the light sensor, a light-based signal from the light sensor may be processed to yield a perfusion pressure on a urinary bladder wall or a urethra.
  • Some embodiments of the disclosed technology relate to a Foley type catheter for sensing pressure-based physiologic data from the urinary tract of a patient having a pressure sensor that includes a pressure interface and a transducer, the sensor not including a pressure-transmitting column. These embodiments typically have a pressure sensing mechanism or transducer proximate the pressure interface.
  • pressure sensors may include, by way of example, any of a piezoelectric electric mechanism, an optical sensing mechanism, a microelectricalmechanical (MEMS) mechanism, or an acoustic wave sensing mechanism.
  • the pressure sensor can transduce pressure impinging on it from the pressure interface into a chronological pressure profile, the pressure profile having sufficient resolution to allow differentiation into one or more physiologic pressure profiles selected from the group consisting of peritoneal pressure, respiratory rate, and cardiac rate.
  • the disclosed technology relates to a Foley type catheter for sensing pressure-based physiologic data from the urinary tract of a patient, as summarized above, but further being enabled to sense a physiologic response to the delivery of pressure, and thereby to determine tissue perfusion pressures.
  • Embodiments of the Foley type catheter include a pressure sensor having a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer.
  • Embodiments of this type further include an expandable pressure-delivery balloon disposed on the catheter so as, upon expansion, to contact a wall of the bladder or the urethra, and a light source and a light sensor disposed proximate the tissue-compressing balloon.
  • an expandable pressure-delivery balloon disposed on the catheter so as, upon expansion, to contact a wall of the bladder or the urethra
  • a light source and a light sensor disposed proximate the tissue-compressing balloon.
  • a light-based signal emanating from the light sensor may be processed to yield a perfusion pressure on a urinary bladder wall or a urethra.
  • Embodiments of the disclosed technology relate to a system for sensing pressure-based physiologic data from the urinary tract of a patient.
  • Embodiments of the system include a Foley type catheter with a pressure sensor having a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer.
  • the pressure transducer can transduce pressure impinging on it from the pressure interface into a chronological pressure profile.
  • Embodiments of the system further include a data processing apparatus in communication with the pressure transducer so as to be able to acquire the physiological data.
  • Embodiments of the data processing apparatus are configured to process the chronological pressure profile into one or more physiologic pressure profiles from the group including peritoneal pressure, respiratory rate, and cardiac rate.
  • the pressure transducer is operable to sample pressure impinging on it at a rate of at least about 1 Hz.
  • the data processing apparatus may be configured to determine relative pulmonary tidal volume.
  • the pressure transducer is operable to sample pressure impinging on it at a rate of at least about 5 Hz.
  • the data processing apparatus may be configured to determine any of cardiac output, relative cardiac output, or absolute cardiac stroke volume.
  • the Foley type catheter may further include a temperature sensor to monitor body temperature.
  • the data processing apparatus may be further configured to acquire and process signals from temperature sensor.
  • the Foley type catheter may further include one or more analyte sensors.
  • the data processing apparatus is further configured to acquire and process signals from the one or more analyte sensors.
  • the data processing apparatus includes a stand-alone console.
  • the stand-alone console includes a bedside unit that is dedicated to monitoring a single patient.
  • the communication between the pressure transducer and the data processing apparatus is wireless.
  • the data processing apparatus includes a networked computer.
  • the networked computer is able to track data from a plurality of patients.
  • the data processing apparatus may include both a stand-alone console and a networked computer.
  • the stand-alone console and the networked computer are in communication with each other.
  • the in communication between the stand-alone console and the networked computer is wireless.
  • the data processing apparatus may include a memory into which a normal range of values for the physiologic data may be entered, and the data processing apparatus may be configured to initiate an alarm when physiologic data of the patient are outside such range of normal values.
  • the data processing apparatus may include a memory configured to receive patient-specific clinical data from a source external to the Foley type catheter, and the data processing apparatus may be configured to integrate such external data and the Foley type catheter-derived physiologic data.
  • Some embodiments of the system may include a controller in communication with the data processing apparatus.
  • the controller may be configured to tune a level of pressure being applied through the fluid column against the proximal side of the pressure interface. Aspects of tuning the pressure level being applied distally against the pressure interface are expanded on below, in the context of summarizing methods provided by the disclosure.
  • the controller may be configured to controllably expand such pressure delivery balloon.
  • the physiologic data from the pressure sensor may be used to track clinical parameters relevant to monitoring intraabdominal hypertension (IAH) or abdominal compartment syndrome (ACS). In other embodiments of the system, the physiologic data from the pressure sensor may be used to track clinical parameters relevant to monitoring any of cardiac status, respiratory status, the onset and progression of hemorrhage or shock, patient bodily movement, or intestinal peristalsis.
  • IAH intraabdominal hypertension
  • ACS abdominal compartment syndrome
  • some embodiments of the disclosed technology relate to a system for sensing pressure-based and temperature-based physiologic data from the urinary tract of a patient, such system including a Foley type catheter with a pressure sensor and a temperature sensor.
  • Embodiments of the pressure sensor have a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer.
  • Embodiments of the system further include a data processing apparatus in communication with the pressure transducer so as to be able to acquire the physiological data.
  • Embodiments of the data processing apparatus are configured to process the chronological pressure profile into one or more physiologic pressure profiles from the group including peritoneal pressure, respiratory rate, and cardiac rate.
  • Embodiments of the data processing apparatus are further configured to acquire and process signals from the temperature sensor, such signals reporting the core body temperature of the patient.
  • Some embodiments of the disclosed technology relate to a system for sensing pressure-based and analyte-based physiologic data from the urinary tract of a patient, such system including a Foley type catheter with a pressure sensor and one or more analyte sensors.
  • Embodiments of the pressure sensor have a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer.
  • Embodiments of the system further include a data processing apparatus in communication with the pressure transducer so as to be able to acquire the physiological data.
  • Embodiments of the data processing apparatus are configured to process the chronological pressure profile into one or more physiologic pressure profiles from the group including peritoneal pressure, respiratory rate, and cardiac rate.
  • Embodiments of the data processing apparatus are further configured to acquire and process analyte signals from the one or more analyte sensors, such signals reporting the level of one or more analytes within the urinary tract.
  • some embodiments of the disclosed technology relate to a system for sensing pressure-based, temperature-based, and analyte-based physiologic data from the urinary tract of a patient, such system including a Foley type catheter with a pressure sensor, a temperature sensor, and one or more analyte sensors.
  • Embodiments of the pressure sensor have a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer.
  • the physiologic data from the any one or more of the sensors may be used to track clinical parameters particularly relevant to monitoring clinical conditions brought about by metabolic diseases or diseases with pathophysiologic metabolic symptoms.
  • the physiologic data from the sensors, the pressure sensor in particular may be used to monitor body movement.
  • Some embodiments of the system include a fluid-collecting receptacle to collect urine drained from the bladder, and the receptacle may include a fluid volume measuring system.
  • the fluid volume measuring system is configured to deliver data from which a urine output rate may be determined.
  • Embodiments of the fluid volume measuring systems may include any of a weight-sensitive system, a fluid height sensing system, a mechanical mechanism, or an optically-sensitive system.
  • Some embodiments of the fluid-collecting receptacle may include a chemical analyte measuring system to identify and/or quantitate analytes such as those summarized for the Foley type catheter itself. More specifically, as example, analyte sensors may be sensitive to any one or more analytes selected from a group consisting of bacteria, blood, hemoglobin, leukocyte esterase, glucose, and particulate matter.
  • Some embodiments of the system may include a docking station to accommodate the collecting receptacle, wherein the docking station and the collecting receptacle are in electrical communication with each other. Communication between the docking station and the collecting receptacle may occur by way of a data transmission line connecting the docking station to the console, or it may occur by way of a wireless communication system.
  • Some embodiments of the system may include a fluid infusion apparatus, with the data processing apparatus being configured to control the activity of the fluid infusion apparatus in response to physiologic data processed by the data processing apparatus.
  • Embodiments of the method include providing a physiologic data monitoring system that includes a Foley type catheter and a data processing apparatus.
  • Embodiments of the Foley type catheter have a pressure sensor, the pressure sensor having a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer, the pressure transducer being able to transduce pressure impinging on it from the fluid column into physiological data comprising a chronological pressure profile.
  • the method may further include inserting the Foley type catheter in the urinary tract such that the pressure interface is residing within the patient's bladder, transferring pressure sensed in the bladder into a transducible chronological pressure profile; and processing the chronological pressure profile into one or more physiologic pressure profiles selected from the group consisting of peritoneal pressure, respiratory rate, and cardiac rate.
  • Tuning pressure refers generally to either increasing or decreasing pressure applied to the proximal side of the pressure interface.
  • Proximal in this context, refers to the side of the pressure interface facing outward from the body (within the communicating fluid column), and toward the main body of the catheter or an operator handling the catheter.
  • tuning the pressure level may refer to priming the fluid column from the proximal end of the column, directing pressure toward the distal end of the column.
  • tuning the pressure level may refer to releasing or bleeding pressure from the proximal end of the column, as may be appropriate, for example, if pressure in the column overshoots a desired pressure level, or if pressure from within the bladder were to decrease.
  • Embodiments of the method may further include repeating the tuning step, as needed, to maintain equivalence between the level of pressure being applied from the proximal side of the pressure interface and the baseline physiologic pressure being applied to a distal side of the pressure interface.
  • Embodiments of the tuning step of the method may include monitoring a physiologic pressure profile, and adjusting the pressure being applied from a proximal side of the pressure interface to a level such that a quality of a physiologic pressure profile being processed by the system is optimized.
  • the amplitude of pressure waves associated with the respiratory rate may be monitored.
  • a high amplitude pressure profile may be considered optimal in that it is generally associated with conditions of equivalence between baseline pressure on either side of the pressure interface.
  • a high amplitude pressure profile may be considered optimal because, other factors being equal, a high amplitude signal permits a higher level of resolution of real differences that may appear in signal level.
  • the monitoring step may be performed automatically by the data processor, and the adjusting step may be performed by an automatic controller in communication with the data processor.
  • a Foley type catheter per embodiments of the disclosed technology, that comprises a thin silicone membrane (e.g., a membrane with a thickness of 0.003 inch) leak about 2 cc of air per hour when under 15 mm Hg of pressure.
  • a thin silicone membrane e.g., a membrane with a thickness of 0.003 inch
  • the method further includes priming the fluid column from the proximal end of the catheter to maintain the balloon at a size that places no substantial strain on the inelastic membrane.
  • the method further include inflating the balloon to a level such that the total surface area of the membrane is substantially taut.
  • the one or more physiologic pressure profiles yielded by processing the chronological pressure profile may provide for monitoring of body movement.
  • Monitoring body movement may be of particular benefit for bed-ridden patients, for example, who have a decubitis ulcer, or are at risk of developing such an ulcer when a portion of the body, such as a bony prominence, rests too long in a pressured position without movement that would relieve such pressure.
  • monitoring body movement may include notifying a health care provider of the level of movement of a patient who is at risk of developing a decubitis ulcer, or at risk of exacerbating an existing decubitis ulcer.
  • monitoring of patient activity may also affirmatively report the presence of movement. In this case, a patient that is a fall risk can be monitored for activity that may indicate an attempt to rise from their bed. This may signal an alert and prevent their mobility without assistance.
  • the method may further include inflating the pressure delivery balloon to a desired pressure, and monitoring the pressure within the expandable balloon to determine the pressure level required to blanche the tissue, said blanching pressure being reflective of a tissue perfusion pressure.
  • the method may further include monitoring the body temperature of the patient. In some embodiments of the method, wherein the Foley type catheter further comprises an analyte sensor, the method further may further include monitoring a level of the analyte within the urine of the patient.
  • FIG. 1 shows a data console in communication with a urine-collecting receptacle docking station, per an embodiment of the sensing Foley catheter system.
  • FIG. 5A shows a sensing Foley catheter with a pressure interface in the form of an inflatable balloon, per an embodiment of the sensing Foley catheter system.
  • FIGS. 6A-6D show various views and details of a sensing Foley catheter, per an embodiment of the sensing Foley catheter system.
  • FIG. 6A schematically arranges the sensing Foley catheter into a proximal section that remains external to the body when in use, a portion that resides in the urethra, and a portion that resides in the bladder, when placed into a human subject.
  • FIG. 6B shows a detailed view of the proximal portion of the catheter.
  • FIG. 6C shows a cross sectional view of the central length of the catheter.
  • FIG. 6D shows a detailed view of the distal portion of the catheter that resides in the bladder.
  • FIG. 7A shows an example of respiratory rate sensing data from a human subject, as provided by an embodiment of the sensing Foley catheter system.
  • the subject performs a respiratory sequence as follows: (1) breath being held at the end of an expiration, (2) valsalva, (3) normal respiration, (4) valsalva, and (5) breath being held at the end of an expiration.
  • FIG. 7B shows a detailed portion of the respiratory profile of FIG. 7A , a portion of the period of normal respiration.
  • FIG. 8 shows an example of cardiac rate and relative cardiac output sensing data from a human subject, as provided by an embodiment of the sensing Foley catheter system, and an EKG trace as measured simultaneously and independently.
  • FIG. 10 shows an example of peritoneal sensing data, with a focus on respiratory rate from a pig, as provided by an embodiment of the sensing Foley catheter system.
  • FIG. 11 shows an example of pig study that demonstrates the capability of an embodiment of the sensing Foley catheter system to detect intra-abdominal hypertension.
  • FIG. 12 shows intraabdominal pressure, respiratory wave pressure, and cardiac pressure schematically arrayed as a two dimensional plot of pressure (mm Hg on a logarithmic scale vs. frequency (Hz).
  • FIG. 13 provides a flow diagram of an embodiment of the method.
  • FIG. 15 shows a graphical representation of data which may be provided to a user.
  • FIGS. 1-4 show various elements of the disclosed technology, including a urine receptacle 60 (holding a urine output 61 ), a docking station 65 to hold the receptacle, an electrical connection 67 that allows communication between the docking station and a data collection and processing apparatus in the form a bedside console 80 .
  • Embodiments of the urine collecting receptacle 60 may include level or volume sensors 62 , as well as other analyte sensors.
  • Receptacle 60 may also include an RFID element that provides a unique identifier to a remote RFID reader 68 .
  • an extender tube 63 may be utilized to convey urine from the catheter to the urine-collecting receptacle.
  • FIG. 1 shows a data receiving and processing apparatus in the form of a bedside console 80 in communication with a receptacle docking station 65 that accommodates a urine collecting receptacle 60 , shown as holding a urine output 61 , per an embodiment of the sensing Foley catheter system.
  • the communication path between the docking station and the console may include a wired connection 67 , as shown, or it may be a wireless connection.
  • the bedside console may record and display output/input data. Physiologic data from sensors associated with a sensing Foley catheter may be held in a memory, displayed, printed, or directly transmitted to a centralized data collection server.
  • Embodiments of the system may include a docking station for the urine collecting receptacle, the docking station being configured for data transmission to a data receiving and processing apparatus such as a bedside console or a networked central computer.
  • the docking station delivers data regarding the volume of urine in the urine receptacle, as well as data that are informative regarding electrical parameters of the urine, such as conductivity, resistance, or impedance. Sensors may also detect and monitor bacteria, hemoglobin, or other substances of clinical significance in urine.
  • FIG. 4 shows a volume-sensing urine receptacle 60 accommodated within a receptacle docking station 65 , per an embodiment of the sensing Foley catheter system.
  • Embodiments of the receptacle may detect urine output based on the levels at which sensors 62 are triggered.
  • the receptacle may include electrical contacts arranged as liquid height-marks, and when an electrical path is made between two contacts and all contacts below, the level can be reported at that level.
  • Embodiments of the receptacle may include electrical, optical, chemical or mechanical sensors.
  • Embodiments of the receptacle may include a capability to report sensing data to the bedside console, locally (e.g., by beeping) or centrally via piping data to a central information collection area. For example, an alert may be triggered if urine output drops below 30 cc/hr. in post-operative setting or below any otherwise predetermined threshold.
  • Embodiments of the receptacle may connect to a docking station through electrical contacts; data communication among embodiments of the receptacle, docking station, and a console or central computer may also be wireless. If a docking station is used, it may detect urine output based on weight or pressure of the receptacle that is applied to base.
  • Embodiments of the urine collecting receptacle may include disposable or durable optical, electrical or chemical sensors capable of sensing and measuring urine content of analytes such as glucose, electrolytes, bacteria, hemoglobin, or blood.
  • Embodiments of the receptacle may include an interface with specifically designed area of the urine receptacle to allow for this measurement, such as an optically clear window for optical measurement of blood.
  • Embodiments of the receptacle docking station may also grasp or accommodate the urine receptacle in any manner so long as it secures the receptacle.
  • the docking station or the receptacle may include an inductive antenna or RFID capabilities to allow for wireless querying and reporting of the level of urine or other fluid collection.
  • FIG. 4 also shows a volume-sensing urine receptacle 60 that includes an RFID chip, per an embodiment of the sensing Foley catheter system.
  • This embodiment may contain RFID circuitry to collect and transmit data directly from within the receptacle to a remote RFID reader 68 .
  • the receptacle may detect impedance, resistance, capacitance or any other electrical or non-electrical property to measure the urine level and report this back to the reader.
  • the reader may then trigger alert if urine output is out of a normal or desirable range.
  • the RFID chip may be capable of detecting changes in optical, chemical, electrical, acoustic or mechanical properties, as well.
  • a urine drainage lumen 23 has a distal opening 41 that resides in the bladder portion 12 of the catheter, and has an opening at the proximal end 14 of the catheter. As seen in FIGS. 2 and 3 , the urine drainage lumen may be connected to an extender tube 63 that conveys the urine to a collecting receptacle. In some embodiments, the drainage lumen and distal opening in the bladder may also serve as in infusion conduit (see FIG. 3 ) by which medicinal agents may be infused, or through which heating or cooling fluid may be infused.
  • Analyte sensors or temperature sensors 50 may be disposed on the catheter, either on the urethral portion 10 or the bladder-residing portion 12 of the catheter. Electrical or optical fiber leads may be disposed in a lumen 25 that allows communication of sensing signals between distally disposed sensors and the proximal portion of the catheter, and then further communication to a data processing apparatus.
  • An inflatable pressure-sensing balloon 38 ( FIGS. 6A, 7A, and 7B ) or a pressure sensing membrane 39 ( FIG. 5B ) arranged across an opening may be positioned on the distal end 12 of the catheter, residing in the bladder.
  • Embodiments of a pressure-sensing balloon or pressure sensing membrane may be understood as comprising a pressure interface having a distal-facing surface exposed to pressure from within the bladder, and a proximal-facing surface exposed to a proximal fluid column.
  • Embodiments of the fluid column (filled with either liquid or gas) may comprise a dedicated lumen, or such column may share a lumen that also serves as a sensing conduit such as lumen 25 .
  • FIG. 5A shows a sensing Foley catheter that includes a pressure interface in the form of pressure-sensing balloon, per an embodiment of the presently disclosed system.
  • Pressure-based physiologic parameters that this catheter embodiment can sense may include, by way of example, peritoneal pressure, respiratory rate, and cardiac rate, relative pulmonary tidal volume profile, cardiac output, relative cardiac output, and absolute cardiac stroke volume.
  • Some embodiments of the Foley type catheter may be further equipped with any of a temperature sensor, one or more analyte sensors, electrodes, and paired light sources and sensors.
  • Embodiments thus further equipped are capable of delivering other forms of physiologic data, as for example, blood pressure, oxygen saturation, pulse oximetry, EKG, and capillary fill pressure.
  • a pressure transducer 20 is further shown connected at the proximal end of the catheter external to the body.
  • FIG. 5B shows a sensing Foley catheter with a lumen (the third lumen, for example) used as a pressure sensing lumen; this embodiment does not include a dedicated pressure-sensing balloon as does the embodiment of FIG. 5A , but instead has a pressure interface in the form of a membrane arranged over a distal opening of the pressure sensing lumen.
  • the sensing Foley catheter is able to detect and report pressure-based physiologic data as included in the embodiment described above.
  • a slow infusion of fluid into the bladder may be accomplished through the third lumen of a standard 3-way Foley catheter, and pressure may be sensed using a pressure sensor in line with this third lumen.
  • all methods associated with processing and responding to pressure-based physiologic data, as described for embodiments with a pressure-sensing balloon, are enabled.
  • FIGS. 6A-6D show various views and details of a sensing Foley catheter, per an embodiment of the sensing Foley catheter system.
  • FIG. 6A schematically arranges the sensing Foley catheter into a proximal section 14 that remains external to the body when in use, a portion 13 that resides in the urethra, and a distal portion 12 that resides in the bladder, when placed into a human subject.
  • FIG. 6B shows a detailed view of the proximal portion of the catheter, focusing on luminal openings 23 , 24 , and 25 , which are configured to make more proximal connections.
  • FIG. 6C shows a cross sectional view of the central length of the catheter, and an example of how lumens 23 , 24 , and 25 may be arranged.
  • FIG. 6D shows a detailed view of the distal portion of the catheter that resides in the bladder, with a particular focus on a retention balloon 36 and a pressure-sensing balloon 38 .
  • Pulse oximetry elements allow for a determination of blood oxygen concentration or saturation, and may be disposed anywhere along the urethral length of the catheter.
  • the sensor or sensors are disposed within the tubing of the device to ensure approximation to the urethral mucosa.
  • a healthcare provider can decompress the bladder with a urinary catheter and obtain pulse oximetry data in a repeatable and accurate manner.
  • the power source for pulse oximetry may be incorporated within the urinary collecting receptacle or within the catheter itself.
  • the pulse oximeter is reusable and the catheter interface is disposable; in this arrangement the pulse oximeter is reversibly attached to the disposable catheter and removed when oxygen measurements are no longer desired.
  • Embodiments of the sensing Foley catheter may include an optically transparent, or sufficiently transparent, channel for the oximetry signal, such as a fiber-optic cable, transparent window, and an interface for the reusable oximeter.
  • This method and device for urethral pulse oximetry may be used in conjunction with any of the other embodiments detailed herein or may be a stand-alone device.
  • Embodiments of the sensing Foley catheter may be able to sense any one or more of a plurality of clinically relevant parameters, such as included in the following examples: urine pH, urine oxygen content, urine nitrate content, respiratory rate, heart rate, perfusion pressure of the bladder wall or the urethral wall, temperature inside the bladder or the urethra, electro-cardiography via sensors on the bladder wall or the urethra, respiratory volume, respiratory pressure, peritoneal pressure, urine glucose, blood glucose via urethral mucosa and/or bladder mucosa, urine proteins, urine hemoglobin, blood pressure.
  • a plurality of clinically relevant parameters such as included in the following examples: urine pH, urine oxygen content, urine nitrate content, respiratory rate, heart rate, perfusion pressure of the bladder wall or the urethral wall, temperature inside the bladder or the urethra, electro-cardiography via sensors on the bladder wall or the urethra, respiratory volume, respiratory pressure, peritoneal pressure, urine glucose, blood glucose via
  • the catheter can sense multiple parameters, but some embodiments may be limited to as few as a single parameter for focused applications (for example, respiratory rate in a patient in respiratory distress).
  • the respiratory rate, relative tidal volume, peritoneal pressure, heart rate and/or relative cardiac output may be measured simultaneously, as well, by connecting a balloon with a flaccid wall or semi-tense wall to an external pressure sensor via a lumen that may be filled with liquid and/or gas.
  • These parameters may be measured, alone or in concert with other parameters, through the use of pressure measurement modalities other than the external pressure sensor. These may include: a deflecting membrane inside of the catheter, MEMs technology, a catheter-based sensor and/or other embodiments.
  • the small peaks on the oscillating respiratory wave, caused by the pumping heart, may be tracked as well by using faster sampling rates (e.g., 5 Hz or greater), and the amplitude of this wave may be used, in the setting of a relatively constant peritoneal pressure, to determine the relative cardiac output, in the setting of a known, stable peritoneal pressure, absolute stroke volume and/or cardiac output.
  • faster sampling rates e.g., 5 Hz or greater
  • the disclosed technology captures a high-resolution chronological profile (pressure as a function of time) of peritoneal pressure that can be transduced and processed into distinct pressure profiles assignable to particular physiologic sources, including peritoneal pressure, respiratory rate, and cardiac rate.
  • peritoneal pressure a high-resolution chronological profile
  • the pressure profile can be further resolved into relative pulmonary tidal volume, cardiac output, relative cardiac output, and absolute cardiac stroke volume.
  • aspects of the disclosed technology relate to fidelity and resolution of a pressure signal generated in response to changes in pressure within the bladder, such changes being reflective of a pressure profile within the peritoneal cavity, such pressure profile including cumulative input from the aforementioned physiologic sources.
  • aspects of the technology further relate to fidelity and resolution of the transduction of the pressure signal into a highly resolvable electrical signal.
  • aspects of the technology relate still further to processing the totality of the electrical signal profile, a surrogate for the pressure profile within the peritoneal cavity, into component profiles that can be assigned to the physiologic sources.
  • the sensitivity of an inflated balloon as a pressure sensor is a function, in part, of the pressure differential across the balloon membrane as a baseline condition.
  • the balloon has the greatest sensitivity to pressure when the baseline pressure differential is near zero. As the baseline pressure differential increases, the sensitivity of the pressure-sensing balloon degrades. Accordingly, the disclosed technology provides an automatic priming method that maintains the balloon in an inflated state, but with a minimal pressure differential.
  • Embodiments of the technology include a pressure interface as may be represented by a balloon having either a compliant membrane or a non-compliant membrane.
  • a pressure interface as may be represented by a balloon having either a compliant membrane or a non-compliant membrane.
  • considerations related to optimizing the pressure around the pressure interface of the device are informed by Boyle's ideal gas law, the relationship between stress and strain as described by Hooke, and by application of Young's modulus.
  • the conditions for optimal sensitivity of a compliant balloon and a non-compliant balloon are slightly different, although, in general, the sensitivity of each is best served by P 1 and P 2 being approximately equal.
  • a non-compliant balloon maximum sensitivity is achieved when P 1 is only slightly above P 2 .
  • the maximum sensitivity is achieved when P 1 is slightly above P 2 at the low end of the (linear) elastic region of the spring constant of the compliant balloon material.
  • the profiles need to be sampled at a rate that is sufficient to resolve the inherent frequency of changes in the profile.
  • This consideration is informed by the Nyquist-Shannon sampling theorem, which states that a sampling frequency of at least 2B samples/second is required to resolve an event that runs at a frequency of B cycles/second.
  • a cardiac rate of 70 beats/minute requires a sampling rate of at least 140 samples/minute to effectively capture the cycle.
  • This relationship underlies aspects of the disclosed technology that specify the sampling rate particularly required to capture physiologic pressure cycles such as relative pulmonary tidal volume, cardiac output, relative cardiac output, and absolute cardiac stroke volume.
  • FIG. 12 shows intraabdominal pressure, respiratory wave pressure, and cardiac pressure schematically arrayed as a two dimensional plot of pressure (mm Htg on a logarithmic scale vs. frequency (Hz). It can be seen that there is an inverse relationship between pressure and frequency, and the various physiologic pressure-related parameters occupy distinct sectors when arrayed in this manner. It is by the distinctness of these profiles that embodiments of the method (see FIG. 14 ), as disclosed herein, can resolve a single overall chronological pressure profile into the distinct subprofiles, in accordance with their physiologic origin.
  • Expandable pressure sensing balloons may assume one of at least two basic forms, type 1 or type 2.
  • type 1 which may be generally likened to a conventional party balloon
  • the pressure-sensing balloon is formed from or includes a compliant or elastic membrane. Accordingly, the surface area of the membrane expands or contracts as a function of the expansion of the balloon. The elasticity of the membrane determines various features of the balloon, as a whole, at different levels of expansion.
  • the balloon if unconstrained, maintains a substantially constant or preferred form or shape, as determined by the mandrel upon which the balloon is formed.
  • the expandable pressure-sensing balloon is formed from or includes a non-compliant, or non-elastic membrane, or a membrane that is substantially non-compliant or non-elastic. Accordingly, the surface area of the membrane does not expand or contract in accordance with the level of balloon expansion.
  • Type 2 pressure-sensing balloons may be generally likened to a conventional Mylar® balloon. The inelasticity of the membrane determines various features of the balloon, as a whole, at different levels of expansion. Upon expansion of the balloon from a minimal volume to a level near its maximal volume, the membrane of the balloon is supple, and has a level of slackness.
  • Expandable pressure sensing balloons may also include features of both of the two basic forms, type 1 or type 2.
  • the membrane may include regions that are elastic (like type 1) and regions that are inelastic (like type 2).
  • a balloon of this hybrid type would, as a whole, behave in a manner drawing from behavioral aspects of both type 1 and type 2 balloons, as described above.
  • type 1 balloons may be formed with a membrane that is not of a homogeneous composition or thickness. In such embodiments, regions of different thickness or composition could have varying degrees of elasticity, thus affecting the behavior of these regions during expansion of the balloon.
  • elasticity of the membrane may have a bias or polarity that tends to permit elasticity in one or more directions, and tends to disallow elasticity in one or more other directions.
  • An aspect of the disclosed technology that is particularly advantageous in achieving a high resolution signal from which pressure profiles from particular physiologic sources (such as peritoneal pressure, respiratory rate, and cardiac rate, relative pulmonary tidal volume, cardiac output, relative cardiac output, and absolute cardiac stroke volume) may be monitored relates to adjusting and maintaining a balance of pressure on either side of the pressure interface represented by the membrane of the pressure sensing balloon.
  • This balance of pressure may be referred to as a pressure differential of zero, or as a zero pressure gauge.
  • Pressure impinging on the external face of balloon is subject to change according to the physiology of the patient.
  • Pressure on the internal face of the balloon (which is in fluid communication with the fluid column) is subject to degradation because of fluid leakage and imperfect seals.
  • Embodiments of the disclosed system and method include automatic pressure tuning by a controller. Accordingly, the tuning system can detect the optimum target pressure and volume to inflate the balloon by monitoring sensed pressure signals and adding or removing air volume as needed. For example, upon insertion of the catheter, a pressure tuning circuit that regulates the balloon volume and pressure will inflate the balloon until it detects a physiologic-sourced pressure rate. Upon sensing that rate, the pressure tuning controller will add or subtract minute amounts of air in a routinized sequence until the amplitude of the sensed wave is greatest. The control feedback loop between the optimally tuned pressure (manifesting as balloon pressure and volume) and the sensed physiologic pressure profile iterates continuously and or as needed to ensure high fidelity measurement of the physiologic data.
  • automatic pressure tuning may be performed in the apparent background while the physiologic data is being transmitted and displayed; in other embodiments the system may suspend transmission of physiologic data during a pressure tuning sequence.
  • Embodiments of the disclosed technology include a gas delivery system that can deliver gas in a priming operation, whereby pressure can be applied to a fluid column proximal to the proximal-facing aspect of the pressure interface.
  • a source of gas such as compressed air or liquid is held in a storage tank.
  • CO 2 is controllably released from the storage tank through a pressure regulator that can step pressure in the tank (for example, pressure of about 850 psi) down to the range of about 1 psi to about 2 psi. Released gas passes through a filter and a pressure relief valve set at about 2.5 psi.
  • the pressure relief valve is a safety feature that prevents flow through of gas at a level greater than 2.5 psi in the event of failure of the upstream regulator.
  • CO 2 exiting the pressure relief valve next passes through a first solenoid-controlled fill valve to enter the catheter line, ultimately filling the balloon that comprises the pressure-sensing interface.
  • Pressure within the balloon is allowed to rise to a level as high as 30 mm Hg, whereupon the first solenoid-controlled valve closes.
  • a second solenoid-controlled valve, distal to the first valve operates as a drain valve, which can release pressure from the catheter to a target pressure.
  • the drain valve may be activated until a respiratory waveform is detected after which the balloon will be optimally primed and the valve will be closed.
  • the drain valve may be subject to proportional control, operably based on voltage or pulse-width modulation (PWM), which allows a drain rate sufficiently slow that the target pressure is reached and the valve can be closed prior to overshoot.
  • PWM pulse-width modulation
  • a peristaltic or other air pump may be utilized to fill the balloon with room air.
  • Intrabdominal pressure or bladder pressure may also be used to detect the level of patient movement (as may vary, for example, between substantially no movement to a high level of movement) and to report the movement level to a healthcare provider.
  • a short burst of peaks and valleys in bladder pressure activity can serve as a proxy for body movement in that such a bladder pressure profile is a strong indicator that the patient is using their abdominal muscles, as, for example, to sit up or get out of bed.
  • This embodiment may be of particular benefit for patients that are at risk of falling.
  • a healthcare provider may be notified that the patient is sitting up and respond accordingly.
  • the device may be used to report inactivity of a patient and/or lack of patient movement.
  • Embodiments of the technology may also report patient movement in the detection or diagnosis of seizure disorder.
  • the pressure variations may trigger an EEG or recording equipment to allow for intense period of monitoring during an episode suspected of being a seizure.
  • a pressure sensor, acoustic sensor or other sensors may be used to detect bowel activity, patient movement, seizure activity, patient shivering, frequency of coughing, severity of coughing, sleep quality, speech detection, patient compliance (movement or lack thereof), and may alert the healthcare provider that the patient has not moved and must be turned or rolled.
  • This movement-related information may also be relayed to a hypothermia device, a drug delivery device or other device to control or mitigate seizure activity, shivering and/or coughing.
  • Embodiments of the technology may also automatically adjust intravenous fluid or drug infusion rates based on feedback from the cardiac output or respiratory rate sensed.
  • a patient-controlled analgesia pump may be deactivated if a respiratory rate drops too low. Respiratory depression can be fatal in this group and this safeguard would prevent overdose.
  • An automated feedback system may also be advantageous in a large volume resuscitation procedure, wherein fluid infusion can be tailored based on intraabdominal pressure to prevent abdominal compartment syndrome by sounding an alert and slowing infusion rates as the intraabdominal pressure rises.
  • Yet another automated feedback feature may provide direct feedback to a ventilator system to provide the optimal pressure of ventilated gas.
  • Embodiments of the technology may also be applied as a correction in the application or understanding of other diagnostic measurements. For example, central venous pressure may be dramatically distorted in the setting of elevated intraabdominal pressure. Providing direct access to these data by the central venous pressure reporting system allows for the automatic correction and accurate reporting of this critical physiologic parameter.
  • Embodiments of the technology may also be used in a variety of other ways to automate therapy including infusion of fluids that may further include active agents, such as pressors or diuretics in response to increased or decreased cardiac output.
  • the Foley type catheter is configured to report the presence of a water droplet or other obstruction in an air-filled lumen, and then handle or resolve the droplet.
  • moisture in an air lumen can condense and form obstructive water droplets.
  • Water droplets in an air-filled lumen can disturb or complicate pressure signals due to the surface tension of the water.
  • a pressure-transmission lumen in some embodiments of the disclosed technology may include a hydrophilic feature (such as a coating on the wall of the lumen itself, or a hydrophilic fiber running the length of the lumen) to wick moisture away from the lumen in order to maintain a continuous, uninterrupted air channel.
  • a hygroscopic composition (silica gel, for example) may be used in line with the air infusion line or within the air infusion lumen itself to capture water or humidity.
  • a hygroscopic composition may be included within the catheter so that the air infusion circuit need not be serviced to replace this material.
  • air may also be intermittently (and automatically) infused and extracted into the pressure-sensing balloon so that the balloon is in a constant state of being optimally primed, as described in further detail above.
  • the air extraction may also contribute to removing and trapping any water from the air line.
  • a hydrophilic fiber or a hydrophilic coating on the inside of the pressure lumen will provide similar benefit in allowing this lumen to handle an air bubble.
  • an air bubble may distort the signal, but the air water interface surface tension is defused by a hydrophilic coating in the lumen of the catheter.
  • a custom extrusion and lumen shape may also be used to prevent obstruction in the case of liquid and/or air-filled lumens.
  • a Foley type catheter may have a lumen that is stellate in cross sectional profile.
  • Such a lumen is generally immune from obstruction by a water droplet, as the droplet tends to cohere to itself and push away from the hydrophobic walls. This behavior tends to disallow filling of a cross-sectional space, and allows for an air channel to remain patent around the water droplet and communicate to the sensor. The same logic applies to an air bubble in water in a hydrophilic, stellate water lumen.
  • the catheter may include an air channel, and a sensor incorporated within the catheter itself or a fluid lumen that is capable of transmitting the pressure back to a sensor.
  • the sensing Foley catheter may include a blood pressure sensing element that may take any of several forms.
  • a blood pressure sensing element includes a pressure delivery balloon 32 (either a separate, dedicated balloon or a balloon in fluid communication with a device retention balloon or a pressure sensing balloon) that can be optically analyzed as it is inflated to determine at which pressure the vessels within the bladder or urethra are blanched and blood flow is stopped.
  • This approach provides a reading of the perfusion pressure of the tissue abutting the pressure delivery balloon, such reading reflective of both the systemic blood pressure and vascular resistance.
  • This embodiment of a perfusion pressure device may be used to provide early detection or monitoring of a variety of acute or emergent medical conditions such as sepsis, shock, hemorrhage, and can be particularly advantageous in detecting these conditions at an early stage.
  • modalities may be used to detect that the tissue has been blanched or ischemic, as well, with the common methodological aspect being that of the intermittent inflation within the lumen, body cavity or bodily tissues to provide the compression of the vasculature.
  • Embodiments of this device and associated methods may also be used to detect perfusion pressure in other areas of the body with an intermittently inflatable member and optical detection of blood flow or the presence of blood.
  • Tissue perfusion information may also be provided by way of sensors disposed on the shaft of the catheter such that they contact the urethral wall when the catheter is in place.
  • These sensing technologies may include microdialysis, pyruvate, lactate, pO 2 , pCO 2 , pH, perfusion index, near-infrared spectroscopy, laser Doppler flowmetry, urethral capnography, and orthogonal polarization spectroscopy. Any of these tests may also be performed on the urine or the bladder wall itself to generate measurements of tissue perfusion.
  • Embodiments of a sensing Foley catheter have been used to collect data from a human subject ( FIGS. 7-9 ) and from a pig ( FIGS. 10-11 ).
  • the human subject was a consenting and well-informed volunteer.
  • FIG. 7A shows an example of respiratory rate sensing data from a human subject, as provided by an embodiment of the sensing Foley catheter system. During this test period, the subject performs a respiratory sequence as follows: (1) breath being held at the end of an expiration, (2) valsalva, (3) normal respiration, (4) valsalva, and (5) breath being held at the end of an expiration.
  • FIG. 7B shows a detailed portion of the respiratory profile of FIG. 8A , a portion of the period of normal respiration.
  • FIG. 8 shows an example of cardiac rate and relative cardiac output sensing data from a human subject, as provided by an embodiment of the sensing Foley catheter system, and an EKG trace as measured simultaneously and independently.
  • FIG. 9 shows data related to relative cardiac output sensing in a human leg raising exercise in which cardiac output increases, as demonstrated by an increased amplitude of the cardiac pulse.
  • FIGS. 10 and 11 were derived from studies done with Buffalo pigs under IACUC-approved protocols.
  • FIG. 10 shows an example of peritoneal sensing data, with a focus on respiratory rate from a pig, as provided by an embodiment of the sensing Foley catheter system.
  • FIG. 11 shows an example of pig study that demonstrates the capability of an embodiment of the sensing Foley catheter system to detect intra-abdominal hypertension.
  • the peritoneal cavity was accessed with a 5 mm Tenamian trocar. The trocar was then attached to a 5 L bag of Lactated Ringers solution via a peristaltic pump, and the solution was infused at a rate of about 1 L per minute. Fluid flow was discontinued once a pressure of about 20 mmHg was obtained after which there was no net fluid flow in or out of the cavity.
  • FIG. 13 provides a flow diagram of an embodiment of the method of monitoring pressure as it occurs dynamically as waves of varied frequency and amplitude in the intraabdominal cavity, as detected from within the urinary bladder.
  • a high fidelity pressure profile is generated and transmitted proximally through a fluid column. More proximally, a pressure transducer converts the high fidelity pressure wave into a high fidelity electrical signal that is informative of pressure frequency and amplitude.
  • the generated high fidelity electrical signal is then processed to yield data subsets that are reflective of components within the overall pressure profile, such subsets being attributable to particular physiologic sources, such as peritoneal pressure, respiratory rate, cardiac rate, relative cardiac output, and patient motion or activity.
  • any one or more features of any embodiment of the invention can be combined with any one or more other features of any other embodiment of the invention, without departing from the scope of the invention. Still further, it should be understood that the invention is not limited to the embodiments that have been set forth for purposes of exemplification, but is to be defined only by a fair reading of claims appended to the patent application, including the full range of equivalency to which each element thereof is entitled.
  • the present invention relates to monitoring patients to determine their whereabouts and correlating this information with their health status.
  • the present invention allows for the use of wireless, satellite or other tracking mechanisms to determine the location of an individual.
  • This location information updated throughout the day, allows for a “time budget” to be provided to the patient and/or healthcare provider.
  • the amount time spent in each location may then be analyzed to determine a change in behavior patterns that may provide early indication of illness.
  • the present invention provides a tracking device, ie a GPS unit, a cell phone, etc., and uses an algorithm to determine where a patient has been spending their time.
  • the patient will define locations, ie home, work, gym, etc. and the tracking device will then report when the patient is within these regions.
  • the region may also be correlated to a map in order to more tightly define the region. This function will allow for better tracking as opposed to just drawing a broad circle around each of these regions and will allow for the patient to be reported as “At Work” even if their work spans many buildings.
  • Preset definitions will also exist which may be correlated to a map and all of such destinations may be bucketed in the same “time budget” category.
  • a user may select a gym from a list of fitness centers then all fitness centers that are members of that gym will be registered as such.
  • the algorithm may be such that once a place (such as a fitness center) is identified as such based on GPS readings, a map may be consulted then all such fitness centers will be labeled as such without the need to define each fitness center individually.
  • the same categorization and grouping applies for all time categories, including work, home (if a user owns two homes), gym, etc.
  • the time spent within each region may then be used to provide a time budget to patients and/or healthcare providers.
  • the data may also, optionally, be anonymized and sent to a healthcare provider.
  • the actual tracking data ie all locations that the patient has visited
  • the device may wirelessly transmit the data to a healthcare provider after, the data has been analyzed and/or anonymized. Changes in movement patterns may then be analyzed by the healthcare provider (or an automated algorithm) and reported.
  • a baseline period of healthy activity may also, preferably, be recorded and analyzed prior to the onset of monitoring so that a baseline may be established for comparison. Psychiatric and physical ailments may then be detected based on high-level locational data and where a user/patient is spending most of their time.
  • FIG. 14 details an example of an algorithm that may be used to report location of a user based on a device that they carry or wear.
  • the algorithm is focused on locating the user and reporting their location as one of four places: HOME, WORK, GYM, COMMUTE, OUT (here used as a catchall for anything other than the first four.
  • FIG. 15 shows a graphical representation of these data which may be provided to a user (so they can more accurately budget their time) or to a healthcare provider, supervisor, etc.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Optics & Photonics (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Social Psychology (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Educational Technology (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Radar, Positioning & Navigation (AREA)
  • Emergency Medicine (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

Foley type catheter embodiments for sensing physiologic data from a urinary tract of a patient are disclosed. The system includes the catheter and a data processing apparatus and methods for sensing physiologic data from the urinary tract. Embodiments may also include a pressure sensor having a pressure interface at a distal end of the catheter, a pressure transducer at a proximal end, and a fluid column disposed between the pressure interface and transducer. When the distal end is residing in the bladder, the pressure transducer can transduce pressure impinging on it into a chronological pressure profile, which can be processed by the data processing apparatus into one or more distinct physiologic pressure profiles, for example, peritoneal pressure, respiratory rate, and cardiac rate. At a sufficiently high data-sampling rate, these physiologic data may further include relative pulmonary tidal volume, cardiac output, relative cardiac output, and absolute cardiac stroke volume.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation of U.S. patent application Ser. No. 13/414,011 filed Mar. 7, 2012, which claims the benefit of U.S. Provisional Application No. 61/464,619, filed Mar. 7, 2011, U.S. Provisional Application No. 61/628,534, filed Nov. 2, 2011, and U.S. Provisional Application No. 61/583,258, filed Jan. 5, 2012. Each of these applications is incorporated herein by reference in its entirety.
TECHNICAL FIELD OF THE INVENTION
The disclosed technology relates to the field of medical devices, in particular devices capable of sensing physiologic data based on sensors incorporated into a catheter adapted to reside in the a urinary tract of a patient.
INCORPORATION BY REFERENCE
All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each such individual publication or patent application were specifically and individually indicated to be so incorporated by reference.
BACKGROUND OF THE INVENTION
The Foley catheter, named for Dr. Frederick Foley who first described a self-retaining balloon catheter in 1929, has been in use since the 1930's, in a form nearly identical to its early models. In its most basic form, a Foley catheter has a proximal portion that remains outside the body, a length that traverses the urethra, and a distal end that resides in the urinary bladder. The Foley catheter is held in place by an inflatable balloon that stabilizes the device in place, and prevents inadvertent withdrawal from the bladder. A typical Foley catheter includes at least two lumens along its length; one lumnen serves as a conduit that drains the bladder, and the second lhunmen serves as an air conduit that allows the balloon to be controllably inflated and deflated.
Various developments have added diagnostic functionality to Foley type catheters, including the ability to measure pressure and temperature. For example, U.S. Pat. No. 5,389,217 of Singer discloses a catheter with oxygen sensing capability. U.S. Pat. No. 5,916,153 of Rhea and U.S. Pat. No. 6,434,418 of Neal both disclose a pressure sensor associated with a Foley type catheter. U.S. Pat. No. 6,602,243 to Noda discloses a temperature sensor associated with a Foley type catheter.
The Foley catheter, widespread in use, having a low cost, and easily put in place by health care professionals may offer still further opportunity as a vehicle for deriving critical diagnostic information. The technology disclosed herein provides for the delivery of highly resolved and previously unavailable diagnostic information, as may be derived from a Foley catheter with pressure sensing capability.
SUMMARY OF THE INVENTION
The disclosed technology relates to a Foley type catheter for sensing physiologic data from the urinary tract of a patient, the physiologic data particularly including those gathered by high fidelity pressure sensing and transduction into signals suitable for processing. In some embodiments, the pressure-sensing Foley type catheter may further be enabled to sense temperature and analytes of clinical significance.
Embodiments of the Foley type catheter include a pressure sensor having a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer. When an embodiment of catheter is appropriately or functionally inserted into the urinary tract of a patient and the distal end is residing in the bladder, the pressure transducer can transduce pressure impinging on it from the pressure interface into a chronological pressure profile. The pressure profile has sufficient resolution to be processed into one or more distinct physiologic pressure profiles, including peritoneal pressure, respiratory rate, and cardiac rate.
In some particular embodiments of the Foley type catheter, the pressure profile generated by the pressure sensor has sufficient resolution such that, when sampled by a transducer at a frequency of at least about 1 Hz, it can be processed to yield a relative pulmonary tidal volume profile. In still further embodiments of the Foley type catheter, the pressure profile generated by the pressure sensor has sufficient resolution such that, when sampled by a transducer at a frequency of at least about 5 Hz, it can be processed to yield physiologic pressure profiles selected from a group consisting of cardiac output, relative cardiac output, and absolute cardiac stroke volume.
In various embodiments of the catheter, the fluid within the fluid column may include a gas, such as air or carbon dioxide, or it may include a liquid. In some embodiments wherein the fluid column includes a liquid, such liquid may include urine, as sourced from the bladder.
In various embodiments of the catheter, the pressure interface may include an elastic membrane or a substantially inelastic membrane. In some embodiments, the pressure interface is substantially homogeneous across its surface area. In other embodiments, the pressure interface can be heterogeneous, having regions that vary in composition or thickness, or having features that provide an elasticity bias.
In particular embodiments of the catheter, the pressure interface includes an expandable balloon. Such an expandable balloon may include either an elastic membrane or a substantially inelastic membrane. Embodiments of the balloon, particularly those having an inelastic membrane, upon expansion, the balloon has a volume in the range of about 0.1 cc to about 2 cc. Other embodiments of the balloon, upon expansion, may have larger volumes, for example, in a range of about 2 cc to about 5 cc, or in a range of about 5 cc to about 250 cc, a volume that is greater than 250 cc. In another aspect, upon inflation, embodiments of the balloon may have a diameter that ranges between about 6 mm and 8 mm.
In various embodiments of the catheter, the pressure interface includes a membrane arranged across an opening. In such embodiments, the membrane is sufficiently elastic to respond to an internal-external pressure differential across its surface.
In some embodiments, the Foley type catheter further includes a temperature sensor to monitor a body core temperature of the patient. In these embodiments, the physiologic data from the temperature sensor in the system may be used to monitor body temperature and to feedback control delivery of a hypothermic treatment regimen. Temperatures sensors appropriate for the Foley type catheter may be of any conventional type, including by way of example, a thermistor, a thermocouple, or an optical temperature sensor.
In some embodiments, the Foley type catheter further includes one or more analyte sensors. Analyte sensors included in the scope of the disclosed technology include sensors for analytes of any clinical significance. For broad examples, such analytes may include any analyte selected from a group including pH, a gas, an electrolyte, a metabolic substrate, a metabolite, an enzyme, or a hormone. By way of particular examples, such analyte sensor may be able to sense any of a metabolic substrate or a metabolite, the analytes may include glucose or lactic acid. By way of example of a hormone, the analyte may include cortisol.
In some embodiments, the Foley type catheter further includes one or more electrodes arranged as electrical activity sensors. Such electrical activity sensors may deliver physiologic data that can be transformed to yield an electrocardiogram (EKG) or an electrogastrogram (EGG).
In some embodiments, the Foley type catheter further includes a light source and a light sensor, the sensor configured to capture light emitted from the light source. In some embodiments, by way of example, the light source and the light sensor may be configured to operate as a pulse oximeter, the light sensor being able to deliver a signal that can be transduced into a pulse rate. In another example, the light source and the light sensor may be configured to operate as an analyte sensor.
Some embodiments of the Foley type catheter may further include an expandable pressure-delivery balloon disposed on the catheter so as, upon expansion, to contact a wall of the bladder or the urethra; and a light source and a light sensor disposed proximate the tissue-compressing balloon. The pressure delivery balloon, the light source, and the light sensor may be arranged such that when the expandable pressure balloon is expanded so as to blanche a tissue surrounding it as detected by the light sensor, a light-based signal from the light sensor may be processed to yield a perfusion pressure on a urinary bladder wall or a urethra.
Some embodiments of the disclosed technology relate to a Foley type catheter for sensing pressure-based physiologic data from the urinary tract of a patient having a pressure sensor that includes a pressure interface and a transducer, the sensor not including a pressure-transmitting column. These embodiments typically have a pressure sensing mechanism or transducer proximate the pressure interface. Such pressure sensors may include, by way of example, any of a piezoelectric electric mechanism, an optical sensing mechanism, a microelectricalmechanical (MEMS) mechanism, or an acoustic wave sensing mechanism. When the catheter is appropriately or functionally inserted into the urinary tract and the distal end is residing in the bladder, the pressure sensor can transduce pressure impinging on it from the pressure interface into a chronological pressure profile, the pressure profile having sufficient resolution to allow differentiation into one or more physiologic pressure profiles selected from the group consisting of peritoneal pressure, respiratory rate, and cardiac rate.
The disclosed technology relates to a Foley type catheter for sensing pressure-based physiologic data from the urinary tract of a patient, as summarized above, but further being enabled to sense a physiologic response to the delivery of pressure, and thereby to determine tissue perfusion pressures. Embodiments of the Foley type catheter include a pressure sensor having a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer. Embodiments of this type further include an expandable pressure-delivery balloon disposed on the catheter so as, upon expansion, to contact a wall of the bladder or the urethra, and a light source and a light sensor disposed proximate the tissue-compressing balloon. When an embodiment of catheter is appropriately or functionally inserted into the urinary tract with the distal end residing in the bladder, the pressure transducer can transduce pressure impinging on it from the pressure interface into a chronological pressure profile. The pressure profile has sufficient resolution to be processed into one or more distinct physiologic pressure profiles, including peritoneal pressure, respiratory rate, and cardiac rate. And when the expandable pressure balloon is expanded so as to blanche a tissue surrounding it (as detected by the light sensor), a light-based signal emanating from the light sensor may be processed to yield a perfusion pressure on a urinary bladder wall or a urethra.
The disclosed technology further relates to a system for sensing and processing physiologic data from the urinary tract of a patient, the physiologic data particularly including those gathered by high fidelity pressure sensing and transduction into signals suitable for processing; these embodiments will now be summarized. In some embodiments, the pressure-sensing Foley type system may further be enabled to sense and process temperature data and/or analyte data of clinical significance these features and embodiments will be summarized further, below.
Thus, particular embodiments of the disclosed technology relate to a system for sensing pressure-based physiologic data from the urinary tract of a patient. Embodiments of the system include a Foley type catheter with a pressure sensor having a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer. When the catheter is appropriately or functionally inserted into the urinary tract and the distal end is residing in the bladder, the pressure transducer can transduce pressure impinging on it from the pressure interface into a chronological pressure profile. Embodiments of the system further include a data processing apparatus in communication with the pressure transducer so as to be able to acquire the physiological data. Embodiments of the data processing apparatus are configured to process the chronological pressure profile into one or more physiologic pressure profiles from the group including peritoneal pressure, respiratory rate, and cardiac rate.
In particular embodiments of the system, the pressure transducer is operable to sample pressure impinging on it at a rate of at least about 1 Hz. In embodiments such as these, the data processing apparatus may be configured to determine relative pulmonary tidal volume. In other particular embodiments of the system, the pressure transducer is operable to sample pressure impinging on it at a rate of at least about 5 Hz. In embodiments such as these, the data processing apparatus may be configured to determine any of cardiac output, relative cardiac output, or absolute cardiac stroke volume.
In particular embodiments of the system, the Foley type catheter may further include a temperature sensor to monitor body temperature. In embodiments such as these, the data processing apparatus may be further configured to acquire and process signals from temperature sensor.
In other embodiments of the system, the Foley type catheter may further include one or more analyte sensors. In embodiments such as these, the data processing apparatus is further configured to acquire and process signals from the one or more analyte sensors.
In some embodiments of the system, the data processing apparatus includes a stand-alone console. In some embodiments, the stand-alone console includes a bedside unit that is dedicated to monitoring a single patient. In some of these types of embodiments, the communication between the pressure transducer and the data processing apparatus is wireless.
In some embodiments of the system, the data processing apparatus includes a networked computer. In some of these types of embodiments, the networked computer is able to track data from a plurality of patients.
In particular embodiments of the system, the data processing apparatus may include both a stand-alone console and a networked computer. In some of these types of embodiments of this type, the stand-alone console and the networked computer are in communication with each other. In particular embodiments, the in communication between the stand-alone console and the networked computer is wireless.
In some embodiments of the system, the data processing apparatus may include a memory into which a normal range of values for the physiologic data may be entered, and the data processing apparatus may be configured to initiate an alarm when physiologic data of the patient are outside such range of normal values.
In some embodiments of the system, the data processing apparatus may include a memory configured to receive patient-specific clinical data from a source external to the Foley type catheter, and the data processing apparatus may be configured to integrate such external data and the Foley type catheter-derived physiologic data.
Some embodiments of the system may include a controller in communication with the data processing apparatus. In such embodiments, the controller may be configured to tune a level of pressure being applied through the fluid column against the proximal side of the pressure interface. Aspects of tuning the pressure level being applied distally against the pressure interface are expanded on below, in the context of summarizing methods provided by the disclosure. Further, in embodiments of the catheter that include a pressure delivery balloon that may be used in a method to measure tissue perfusion pressure, the controller may be configured to controllably expand such pressure delivery balloon.
In some embodiments of the system, the physiologic data from the pressure sensor may be used to track clinical parameters relevant to monitoring intraabdominal hypertension (IAH) or abdominal compartment syndrome (ACS). In other embodiments of the system, the physiologic data from the pressure sensor may be used to track clinical parameters relevant to monitoring any of cardiac status, respiratory status, the onset and progression of hemorrhage or shock, patient bodily movement, or intestinal peristalsis.
As noted above, some embodiments of the disclosed technology relate to a system for sensing pressure-based and temperature-based physiologic data from the urinary tract of a patient, such system including a Foley type catheter with a pressure sensor and a temperature sensor. Embodiments of the pressure sensor have a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer. When the catheter is appropriately or functionally inserted into the urinary tract and the distal end is residing in the bladder, the pressure transducer transduces pressure impinging on it from the fluid column into physiological data comprising a chronological pressure profile. Embodiments of the system further include a data processing apparatus in communication with the pressure transducer so as to be able to acquire the physiological data. Embodiments of the data processing apparatus are configured to process the chronological pressure profile into one or more physiologic pressure profiles from the group including peritoneal pressure, respiratory rate, and cardiac rate. Embodiments of the data processing apparatus are further configured to acquire and process signals from the temperature sensor, such signals reporting the core body temperature of the patient.
Some embodiments of the disclosed technology relate to a system for sensing pressure-based and analyte-based physiologic data from the urinary tract of a patient, such system including a Foley type catheter with a pressure sensor and one or more analyte sensors. Embodiments of the pressure sensor have a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer. When the catheter is appropriately or functionally inserted into the urinary tract and the distal end is residing in the bladder, the pressure transducer transduces pressure impinging on it from the fluid column into physiological data comprising a chronological pressure profile. Embodiments of the system further include a data processing apparatus in communication with the pressure transducer so as to be able to acquire the physiological data. Embodiments of the data processing apparatus are configured to process the chronological pressure profile into one or more physiologic pressure profiles from the group including peritoneal pressure, respiratory rate, and cardiac rate. Embodiments of the data processing apparatus are further configured to acquire and process analyte signals from the one or more analyte sensors, such signals reporting the level of one or more analytes within the urinary tract.
As noted above, some embodiments of the disclosed technology relate to a system for sensing pressure-based, temperature-based, and analyte-based physiologic data from the urinary tract of a patient, such system including a Foley type catheter with a pressure sensor, a temperature sensor, and one or more analyte sensors. Embodiments of the pressure sensor have a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer. When the catheter is appropriately or functionally inserted into the urinary tract and the distal end is residing in the bladder, the pressure transducer transduces pressure impinging on it from the fluid column into physiological data comprising a chronological pressure profile. Embodiments of the system further include a data processing apparatus in communication with the pressure transducer so as to be able to acquire the physiological data. Embodiments of the data processing apparatus are configured to process the chronological pressure profile into one or more physiologic pressure profiles from the group including peritoneal pressure, respiratory rate, and cardiac rate. Embodiments of the data processing apparatus are further configured to acquire and process signals from the temperature sensor, such signals reporting the core body temperature of the patient. Embodiments of the data processing apparatus are further configured to acquire and process analyte signals from the one or more analyte sensors, such signals reporting the level of one or more analytes within the urinary tract.
In some embodiments of the system, the physiologic data from the any one or more of the sensors (pressure sensor, temperature sensor, and/or analyte sensor) may be used to track clinical parameters particularly relevant to monitoring clinical conditions brought about by metabolic diseases or diseases with pathophysiologic metabolic symptoms. For example, embodiments of the system may be used to monitor clinical parameters relevant to kidney function or diabetes. In other embodiments of the method, the physiologic data from the sensors, the pressure sensor in particular, may be used to monitor body movement.
Some embodiments of the system include a fluid-collecting receptacle to collect urine drained from the bladder, and the receptacle may include a fluid volume measuring system. In some of such embodiments, the fluid volume measuring system is configured to deliver data from which a urine output rate may be determined. Embodiments of the fluid volume measuring systems may include any of a weight-sensitive system, a fluid height sensing system, a mechanical mechanism, or an optically-sensitive system.
Some embodiments of the fluid-collecting receptacle may include a chemical analyte measuring system to identify and/or quantitate analytes such as those summarized for the Foley type catheter itself. More specifically, as example, analyte sensors may be sensitive to any one or more analytes selected from a group consisting of bacteria, blood, hemoglobin, leukocyte esterase, glucose, and particulate matter.
Some embodiments of the fluid-collecting receptacle may include an RFID chip for identification of the receptacle in communications with a data processing apparatus, or for conveying sensed data to the data processing apparatus.
Some embodiments of the system may include a docking station to accommodate the collecting receptacle, wherein the docking station and the collecting receptacle are in electrical communication with each other. Communication between the docking station and the collecting receptacle may occur by way of a data transmission line connecting the docking station to the console, or it may occur by way of a wireless communication system.
Some embodiments of the system may include a fluid infusion apparatus, with the data processing apparatus being configured to control the activity of the fluid infusion apparatus in response to physiologic data processed by the data processing apparatus.
Some embodiments of the disclosed technology relate to a method for monitoring physiologic data from the urinary tract of a patient. These physiologic data particularly include pressure-based data, but may further include temperature-based data and analyte-based data. In still further embodiments, delivery of pressure in combination with light-based data to yield tissue perfusion pressure values.
Embodiments of the method include providing a physiologic data monitoring system that includes a Foley type catheter and a data processing apparatus. Embodiments of the Foley type catheter have a pressure sensor, the pressure sensor having a pressure interface disposed at a distal end of the catheter, a pressure transducer at a proximal end of the catheter, and a fluid column disposed between the pressure interface and the pressure transducer, the pressure transducer being able to transduce pressure impinging on it from the fluid column into physiological data comprising a chronological pressure profile. The method may further include inserting the Foley type catheter in the urinary tract such that the pressure interface is residing within the patient's bladder, transferring pressure sensed in the bladder into a transducible chronological pressure profile; and processing the chronological pressure profile into one or more physiologic pressure profiles selected from the group consisting of peritoneal pressure, respiratory rate, and cardiac rate.
Some embodiments of the method include tuning or priming a level of pressure being applied from a proximal side of the pressure interface of a Foley type catheter toward equivalence with a baseline physiologic pressure being applied to a distal side of the pressure interface. Tuning pressure refers generally to either increasing or decreasing pressure applied to the proximal side of the pressure interface. Proximal, in this context, refers to the side of the pressure interface facing outward from the body (within the communicating fluid column), and toward the main body of the catheter or an operator handling the catheter. In one aspect, tuning the pressure level may refer to priming the fluid column from the proximal end of the column, directing pressure toward the distal end of the column. In another aspect, tuning the pressure level may refer to releasing or bleeding pressure from the proximal end of the column, as may be appropriate, for example, if pressure in the column overshoots a desired pressure level, or if pressure from within the bladder were to decrease. Embodiments of the method may further include repeating the tuning step, as needed, to maintain equivalence between the level of pressure being applied from the proximal side of the pressure interface and the baseline physiologic pressure being applied to a distal side of the pressure interface.
Embodiments of the tuning step of the method may include monitoring a physiologic pressure profile, and adjusting the pressure being applied from a proximal side of the pressure interface to a level such that a quality of a physiologic pressure profile being processed by the system is optimized. By way of example, the amplitude of pressure waves associated with the respiratory rate may be monitored. A high amplitude pressure profile may be considered optimal in that it is generally associated with conditions of equivalence between baseline pressure on either side of the pressure interface. In another aspect, a high amplitude pressure profile may be considered optimal because, other factors being equal, a high amplitude signal permits a higher level of resolution of real differences that may appear in signal level. In some embodiments, the monitoring step may be performed automatically by the data processor, and the adjusting step may be performed by an automatic controller in communication with the data processor.
The necessity to prime the catheter is driven, at least in part, by leakage of gas from the fluid column. It has been observed, for example, that a Foley type catheter, per embodiments of the disclosed technology, that comprises a thin silicone membrane (e.g., a membrane with a thickness of 0.003 inch) leak about 2 cc of air per hour when under 15 mm Hg of pressure.
Some embodiments of the method may include applying pressure to the proximal side of the pressure interface by delivering gas under pressure to a space proximal to the pressure interface. Delivering gas to the space proximal the pressure interface may be considered priming the space or tuning the space so as to equilibrate or substantially equilibrate pressure on either side of the pressure interface. The source of the gas, per embodiments of the technology, is typically a compressed gas cylinder. Any suitable biologically compatible gas may be used, including, by way of example, air or carbon dioxide.
In some embodiments of the method, appropriate for those in which the pressure interface includes a balloon formed from an inelastic membrane, the method further includes priming the fluid column from the proximal end of the catheter to maintain the balloon at a size that places no substantial strain on the inelastic membrane.
In some embodiments of the method, appropriate for those in which the pressure interface includes a balloon formed from an inelastic membrane having a total surface area, the method further include inflating the balloon to a level such that the total surface area of the membrane is substantially taut.
Some embodiments of the method include sampling the pressure profile impinging on the transducer at a frequency of at least 1 Hz, the method further comprising quantifying respiratory excursions relative to a baseline magnitude of excursions proximate the time of catheter insertion. These embodiments may particularly include monitoring the relative amplitude of respiratory pressure wave excursions, and relating such relative amplitude to relative respiratory tidal volumes.
Some embodiments of the method include sampling the pressure profile impinging on the transducer at a frequency of at least 5 Hz, the method further including quantifying peaks on the respiratory pressure wave that are associated with the cardiac rate. In particular embodiments of this type, against a background of a substantially stable peritoneal pressure, the method may further include determining any of cardiac output, relative cardiac output, respiratory tidal volume, or absolute cardiac stroke volume.
In some embodiments of the method, the one or more physiologic pressure profiles yielded by processing the chronological pressure profile may provide for monitoring of body movement. Monitoring body movement may be of particular benefit for bed-ridden patients, for example, who have a decubitis ulcer, or are at risk of developing such an ulcer when a portion of the body, such as a bony prominence, rests too long in a pressured position without movement that would relieve such pressure. Accordingly, monitoring body movement may include notifying a health care provider of the level of movement of a patient who is at risk of developing a decubitis ulcer, or at risk of exacerbating an existing decubitis ulcer. In addition, monitoring of patient activity may also affirmatively report the presence of movement. In this case, a patient that is a fall risk can be monitored for activity that may indicate an attempt to rise from their bed. This may signal an alert and prevent their mobility without assistance.
In some embodiments of the method, wherein the Foley type catheter has an expandable pressure delivery balloon, a light source and a light sensor proximate the expandable pressure balloon (the light sensor configured to capture light from the light source) the method may further include inflating the pressure delivery balloon to a desired pressure, and monitoring the pressure within the expandable balloon to determine the pressure level required to blanche the tissue, said blanching pressure being reflective of a tissue perfusion pressure.
In some embodiments of the method, wherein the Foley type catheter has a temperature sensor, the method may further include monitoring the body temperature of the patient. In some embodiments of the method, wherein the Foley type catheter further comprises an analyte sensor, the method further may further include monitoring a level of the analyte within the urine of the patient.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows a data console in communication with a urine-collecting receptacle docking station, per an embodiment of the sensing Foley catheter system.
FIG. 2 shows an embodiment of the sensing Foley catheter system set up to measure urine output from a human subject.
FIG. 3 shows an embodiment of the sensing Foley catheter system set up as an automated infusion therapy system for a human subject.
FIG. 4 shows a volume-sensing urine collecting receptacle that includes an RFID chip, the receptacle accommodated within a receptacle docking station, per an embodiment of the sensing Foley catheter system.
FIG. 5A shows a sensing Foley catheter with a pressure interface in the form of an inflatable balloon, per an embodiment of the sensing Foley catheter system.
FIG. 5B shows a sensing Foley catheter a pressure interface in the form of a membrane arranged across a luminal opening, per an embodiment of the sensing Foley catheter system.
FIGS. 6A-6D show various views and details of a sensing Foley catheter, per an embodiment of the sensing Foley catheter system. FIG. 6A schematically arranges the sensing Foley catheter into a proximal section that remains external to the body when in use, a portion that resides in the urethra, and a portion that resides in the bladder, when placed into a human subject.
FIG. 6B shows a detailed view of the proximal portion of the catheter.
FIG. 6C shows a cross sectional view of the central length of the catheter.
FIG. 6D shows a detailed view of the distal portion of the catheter that resides in the bladder.
FIG. 7A shows an example of respiratory rate sensing data from a human subject, as provided by an embodiment of the sensing Foley catheter system. During this test period, the subject performs a respiratory sequence as follows: (1) breath being held at the end of an expiration, (2) valsalva, (3) normal respiration, (4) valsalva, and (5) breath being held at the end of an expiration.
FIG. 7B shows a detailed portion of the respiratory profile of FIG. 7A, a portion of the period of normal respiration.
FIG. 8 shows an example of cardiac rate and relative cardiac output sensing data from a human subject, as provided by an embodiment of the sensing Foley catheter system, and an EKG trace as measured simultaneously and independently.
FIG. 9 shows data related to relative cardiac output sensing in a human leg raising exercise in which cardiac output increases, as demonstrated by an increased amplitude of the cardiac pulse.
FIG. 10 shows an example of peritoneal sensing data, with a focus on respiratory rate from a pig, as provided by an embodiment of the sensing Foley catheter system.
FIG. 11 shows an example of pig study that demonstrates the capability of an embodiment of the sensing Foley catheter system to detect intra-abdominal hypertension.
FIG. 12 shows intraabdominal pressure, respiratory wave pressure, and cardiac pressure schematically arrayed as a two dimensional plot of pressure (mm Hg on a logarithmic scale vs. frequency (Hz).
FIG. 13 provides a flow diagram of an embodiment of the method.
FIG. 14 details an example of an algorithm that may be used to report location of a user based on a device that they carry or wear.
FIG. 15 shows a graphical representation of data which may be provided to a user.
DETAILED DESCRIPTION OF THE DISCLOSURE
FIGS. 1-4 show various elements of the disclosed technology, including a urine receptacle 60 (holding a urine output 61), a docking station 65 to hold the receptacle, an electrical connection 67 that allows communication between the docking station and a data collection and processing apparatus in the form a bedside console 80. Embodiments of the urine collecting receptacle 60 may include level or volume sensors 62, as well as other analyte sensors. Receptacle 60 may also include an RFID element that provides a unique identifier to a remote RFID reader 68. In some embodiments, an extender tube 63 may be utilized to convey urine from the catheter to the urine-collecting receptacle.
FIG. 1 shows a data receiving and processing apparatus in the form of a bedside console 80 in communication with a receptacle docking station 65 that accommodates a urine collecting receptacle 60, shown as holding a urine output 61, per an embodiment of the sensing Foley catheter system. The communication path between the docking station and the console may include a wired connection 67, as shown, or it may be a wireless connection. The bedside console may record and display output/input data. Physiologic data from sensors associated with a sensing Foley catheter may be held in a memory, displayed, printed, or directly transmitted to a centralized data collection server.
In some embodiments, the bedside console or controller is portable and able to travel with the patient. Embodiments of console may be attachable to a patient's bed or an IV pole, or a wall mount; it typically has its own display, and is able to provide critical alerts. Some embodiments of console may be adapted to be able to operate on a battery backup for 4 or more hours, as for example when wall power is unavailable or has been lost. This portability feature of console is advantageous in situations where patients are typically not being electronically monitored, such as when a patient is in transit from his or her bed to another location. Embodiments of console may also be configured to communicate to a base station with alerts and centralized reporting and data collection. A controller or base station may also generate mobile alerts that may be sent to nurses or healthcare provider. Signal analysis and/or predictive algorithms may also be used to provide useful clinical data from sensors.
FIG. 2 shows elements of an embodiment of the sensing Foley catheter system configured to measure urine output from a human subject. In some embodiments, the bedside console 80 or an RFID reader (see FIG. 5) is enabled to trigger an alert if urine output is above or below a preset normal or desired range for urine output over a set period of time. Some embodiments of the system may also have an intravenous infusion capability (see FIG. 3) to provide use sensed data to regulate delivery of fluids or medicinal agents such as a diuretic drug, by way of an automated system based on the urine output feedback. Embodiments of the system may include a docking station for the urine collecting receptacle, the docking station being configured for data transmission to a data receiving and processing apparatus such as a bedside console or a networked central computer. In some embodiments, the docking station delivers data regarding the volume of urine in the urine receptacle, as well as data that are informative regarding electrical parameters of the urine, such as conductivity, resistance, or impedance. Sensors may also detect and monitor bacteria, hemoglobin, or other substances of clinical significance in urine.
FIG. 3 shows an embodiment of the sensing Foley catheter system configured as an automated infusion therapy system for a human subject. A bedside console 80 may integrate patient data, such as fluids received or urine output recorded, and then automate therapeutic infusion in response to these data. For example, delivery of fluids or drug solutions such as a physiological saline solution may be initiated or regulated through an infusion line 82 if the patient is dehydrated, or a diuretic may be infused if the patient is fluid overloaded. In some embodiments, the console may trigger a local alert (e.g., audible beeping), or trigger a centralized alert (e.g., a system alarm) if urine output drops too low. The console may also integrate a hydrating or medicinal fluid infusion capability, such as an IV infusion pump, and may adjust infusion rates based on these data or based on data acquired from other sensors automatically. The console may communicate wirelessly, as well, to these and other sensors within the body.
FIG. 4 shows a volume-sensing urine receptacle 60 accommodated within a receptacle docking station 65, per an embodiment of the sensing Foley catheter system. Embodiments of the receptacle may detect urine output based on the levels at which sensors 62 are triggered. For example, the receptacle may include electrical contacts arranged as liquid height-marks, and when an electrical path is made between two contacts and all contacts below, the level can be reported at that level. Embodiments of the receptacle may include electrical, optical, chemical or mechanical sensors. Embodiments of the receptacle may include also contain diffuse or discrete sensing areas that detect analytes of interest, e.g., hemoglobin, protein, glucose, bacteria, blood, leukocyte esterase. Sensing or data reporting of sensed data may be of either an intermittent or a continuous nature.
Embodiments of the receptacle may include a capability to report sensing data to the bedside console, locally (e.g., by beeping) or centrally via piping data to a central information collection area. For example, an alert may be triggered if urine output drops below 30 cc/hr. in post-operative setting or below any otherwise predetermined threshold. Embodiments of the receptacle may connect to a docking station through electrical contacts; data communication among embodiments of the receptacle, docking station, and a console or central computer may also be wireless. If a docking station is used, it may detect urine output based on weight or pressure of the receptacle that is applied to base.
Embodiments of the urine collecting receptacle may include disposable or durable optical, electrical or chemical sensors capable of sensing and measuring urine content of analytes such as glucose, electrolytes, bacteria, hemoglobin, or blood. Embodiments of the receptacle may include an interface with specifically designed area of the urine receptacle to allow for this measurement, such as an optically clear window for optical measurement of blood. Embodiments of the receptacle docking station may also grasp or accommodate the urine receptacle in any manner so long as it secures the receptacle. The docking station or the receptacle may include an inductive antenna or RFID capabilities to allow for wireless querying and reporting of the level of urine or other fluid collection.
The embodiment of FIG. 4 also shows a volume-sensing urine receptacle 60 that includes an RFID chip, per an embodiment of the sensing Foley catheter system. This embodiment may contain RFID circuitry to collect and transmit data directly from within the receptacle to a remote RFID reader 68. When queried by the RFID reader, the receptacle may detect impedance, resistance, capacitance or any other electrical or non-electrical property to measure the urine level and report this back to the reader. The reader may then trigger alert if urine output is out of a normal or desirable range. The RFID chip may be capable of detecting changes in optical, chemical, electrical, acoustic or mechanical properties, as well. RFID chips may be active or passive, and may contain an antenna to transmit a receptacle-identifying signal to the reader, and allow multiple receptacles to be queried simultaneously. An active RFID chip may incorporate a small battery (to extend its range). A passive RFID chip may be powered by the transmission from the RFID reader. The RFID reader may query a device from a distance to wirelessly check the urine output level or it may be centralized to query all receptacles within a unit, floor or hospital and issue an alert if urine output is out of a normal or desirable range. The RFID reader record urine output, as well, and functionally replace the individual unit console shown in FIGS. 1-3. The RFID reader may also report data from other sensors within the system, including bladder temperature or presence of analytes (as detailed elsewhere) in the urine.
FIGS. 5A-6D show embodiments of a sensing Foley catheter 10 and various of its features. A catheter may be understood to have various sections according to their disposition when the catheter is inserted into a human subject, such as a proximal portion 14 that remains external to the subject, a central or urethra-residing portion 13, and a distal or urinary bladder-residing portion 12.
Various internal lumens traverse the length of the catheter, such as an air or fluid 24 that communicates with a bladder retention balloon 36. A urine drainage lumen 23 has a distal opening 41 that resides in the bladder portion 12 of the catheter, and has an opening at the proximal end 14 of the catheter. As seen in FIGS. 2 and 3, the urine drainage lumen may be connected to an extender tube 63 that conveys the urine to a collecting receptacle. In some embodiments, the drainage lumen and distal opening in the bladder may also serve as in infusion conduit (see FIG. 3) by which medicinal agents may be infused, or through which heating or cooling fluid may be infused. Analyte sensors or temperature sensors 50 may be disposed on the catheter, either on the urethral portion 10 or the bladder-residing portion 12 of the catheter. Electrical or optical fiber leads may be disposed in a lumen 25 that allows communication of sensing signals between distally disposed sensors and the proximal portion of the catheter, and then further communication to a data processing apparatus.
An inflatable pressure-sensing balloon 38 (FIGS. 6A, 7A, and 7B) or a pressure sensing membrane 39 (FIG. 5B) arranged across an opening may be positioned on the distal end 12 of the catheter, residing in the bladder. Embodiments of a pressure-sensing balloon or pressure sensing membrane may be understood as comprising a pressure interface having a distal-facing surface exposed to pressure from within the bladder, and a proximal-facing surface exposed to a proximal fluid column. Embodiments of the fluid column (filled with either liquid or gas) may comprise a dedicated lumen, or such column may share a lumen that also serves as a sensing conduit such as lumen 25.
FIG. 5A shows a sensing Foley catheter that includes a pressure interface in the form of pressure-sensing balloon, per an embodiment of the presently disclosed system. Pressure-based physiologic parameters that this catheter embodiment can sense may include, by way of example, peritoneal pressure, respiratory rate, and cardiac rate, relative pulmonary tidal volume profile, cardiac output, relative cardiac output, and absolute cardiac stroke volume. Some embodiments of the Foley type catheter may be further equipped with any of a temperature sensor, one or more analyte sensors, electrodes, and paired light sources and sensors. Embodiments thus further equipped are capable of delivering other forms of physiologic data, as for example, blood pressure, oxygen saturation, pulse oximetry, EKG, and capillary fill pressure. A pressure transducer 20 is further shown connected at the proximal end of the catheter external to the body.
FIG. 5B shows a sensing Foley catheter with a lumen (the third lumen, for example) used as a pressure sensing lumen; this embodiment does not include a dedicated pressure-sensing balloon as does the embodiment of FIG. 5A, but instead has a pressure interface in the form of a membrane arranged over a distal opening of the pressure sensing lumen. In this embodiment, the sensing Foley catheter is able to detect and report pressure-based physiologic data as included in the embodiment described above. In this present embodiment, a slow infusion of fluid into the bladder may be accomplished through the third lumen of a standard 3-way Foley catheter, and pressure may be sensed using a pressure sensor in line with this third lumen. In this embodiment, all methods associated with processing and responding to pressure-based physiologic data, as described for embodiments with a pressure-sensing balloon, are enabled.
FIGS. 6A-6D show various views and details of a sensing Foley catheter, per an embodiment of the sensing Foley catheter system. FIG. 6A schematically arranges the sensing Foley catheter into a proximal section 14 that remains external to the body when in use, a portion 13 that resides in the urethra, and a distal portion 12 that resides in the bladder, when placed into a human subject. FIG. 6B shows a detailed view of the proximal portion of the catheter, focusing on luminal openings 23, 24, and 25, which are configured to make more proximal connections. FIG. 6C shows a cross sectional view of the central length of the catheter, and an example of how lumens 23, 24, and 25 may be arranged. FIG. 6D shows a detailed view of the distal portion of the catheter that resides in the bladder, with a particular focus on a retention balloon 36 and a pressure-sensing balloon 38.
Pulse oximetry elements allow for a determination of blood oxygen concentration or saturation, and may be disposed anywhere along the urethral length of the catheter. In some embodiments, the sensor or sensors are disposed within the tubing of the device to ensure approximation to the urethral mucosa. With this technology, a healthcare provider can decompress the bladder with a urinary catheter and obtain pulse oximetry data in a repeatable and accurate manner. The power source for pulse oximetry may be incorporated within the urinary collecting receptacle or within the catheter itself. In some embodiments, the pulse oximeter is reusable and the catheter interface is disposable; in this arrangement the pulse oximeter is reversibly attached to the disposable catheter and removed when oxygen measurements are no longer desired. Embodiments of the sensing Foley catheter may include an optically transparent, or sufficiently transparent, channel for the oximetry signal, such as a fiber-optic cable, transparent window, and an interface for the reusable oximeter. This method and device for urethral pulse oximetry may be used in conjunction with any of the other embodiments detailed herein or may be a stand-alone device.
Embodiments of the sensing Foley catheter may be able to sense any one or more of a plurality of clinically relevant parameters, such as included in the following examples: urine pH, urine oxygen content, urine nitrate content, respiratory rate, heart rate, perfusion pressure of the bladder wall or the urethral wall, temperature inside the bladder or the urethra, electro-cardiography via sensors on the bladder wall or the urethra, respiratory volume, respiratory pressure, peritoneal pressure, urine glucose, blood glucose via urethral mucosa and/or bladder mucosa, urine proteins, urine hemoglobin, blood pressure. In some embodiments, the catheter can sense multiple parameters, but some embodiments may be limited to as few as a single parameter for focused applications (for example, respiratory rate in a patient in respiratory distress). The respiratory rate, relative tidal volume, peritoneal pressure, heart rate and/or relative cardiac output may be measured simultaneously, as well, by connecting a balloon with a flaccid wall or semi-tense wall to an external pressure sensor via a lumen that may be filled with liquid and/or gas.
These parameters may be measured, alone or in concert with other parameters, through the use of pressure measurement modalities other than the external pressure sensor. These may include: a deflecting membrane inside of the catheter, MEMs technology, a catheter-based sensor and/or other embodiments.
Relative cardiac output and relative tidal volume may also be calculated, based on the deflection of the pressure sensor and/or other force gauge. If sampled with sufficient frequency (e.g., 1 Hz or greater), respiratory excursions can be quantified in a relative manner to the amplitude of the excursions at the time of catheter placement. Larger excursions generally relate to heavier breathing, or in the setting of an upward drift in the baseline, a higher peritoneal pressure. The small peaks on the oscillating respiratory wave, caused by the pumping heart, may be tracked as well by using faster sampling rates (e.g., 5 Hz or greater), and the amplitude of this wave may be used, in the setting of a relatively constant peritoneal pressure, to determine the relative cardiac output, in the setting of a known, stable peritoneal pressure, absolute stroke volume and/or cardiac output.
The disclosed technology captures a high-resolution chronological profile (pressure as a function of time) of peritoneal pressure that can be transduced and processed into distinct pressure profiles assignable to particular physiologic sources, including peritoneal pressure, respiratory rate, and cardiac rate. By tracking the pressure profile at a sufficiently rapid sampling rate, as provided by the technology, the pressure profile can be further resolved into relative pulmonary tidal volume, cardiac output, relative cardiac output, and absolute cardiac stroke volume.
Accordingly, aspects of the disclosed technology relate to fidelity and resolution of a pressure signal generated in response to changes in pressure within the bladder, such changes being reflective of a pressure profile within the peritoneal cavity, such pressure profile including cumulative input from the aforementioned physiologic sources. Aspects of the technology further relate to fidelity and resolution of the transduction of the pressure signal into a highly resolvable electrical signal. Aspects of the technology relate still further to processing the totality of the electrical signal profile, a surrogate for the pressure profile within the peritoneal cavity, into component profiles that can be assigned to the physiologic sources.
The sensitivity of an inflated balloon as a pressure sensor is a function, in part, of the pressure differential across the balloon membrane as a baseline condition. The balloon has the greatest sensitivity to pressure when the baseline pressure differential is near zero. As the baseline pressure differential increases, the sensitivity of the pressure-sensing balloon degrades. Accordingly, the disclosed technology provides an automatic priming method that maintains the balloon in an inflated state, but with a minimal pressure differential.
Embodiments of the technology include a pressure interface as may be represented by a balloon having either a compliant membrane or a non-compliant membrane. In general, considerations related to optimizing the pressure around the pressure interface of the device are informed by Boyle's ideal gas law, the relationship between stress and strain as described by Hooke, and by application of Young's modulus. The conditions for optimal sensitivity of a compliant balloon and a non-compliant balloon are slightly different, although, in general, the sensitivity of each is best served by P1 and P2 being approximately equal. A non-compliant balloon maximum sensitivity is achieved when P1 is only slightly above P2. For a compliant balloon, the maximum sensitivity is achieved when P1 is slightly above P2 at the low end of the (linear) elastic region of the spring constant of the compliant balloon material.
To effectively capture physiologic pressure profiles, the profiles need to be sampled at a rate that is sufficient to resolve the inherent frequency of changes in the profile. This consideration is informed by the Nyquist-Shannon sampling theorem, which states that a sampling frequency of at least 2B samples/second is required to resolve an event that runs at a frequency of B cycles/second. As applied to a physiologic pressure cycle, for example, a cardiac rate of 70 beats/minute requires a sampling rate of at least 140 samples/minute to effectively capture the cycle. This relationship underlies aspects of the disclosed technology that specify the sampling rate particularly required to capture physiologic pressure cycles such as relative pulmonary tidal volume, cardiac output, relative cardiac output, and absolute cardiac stroke volume.
FIG. 12 shows intraabdominal pressure, respiratory wave pressure, and cardiac pressure schematically arrayed as a two dimensional plot of pressure (mm Htg on a logarithmic scale vs. frequency (Hz). It can be seen that there is an inverse relationship between pressure and frequency, and the various physiologic pressure-related parameters occupy distinct sectors when arrayed in this manner. It is by the distinctness of these profiles that embodiments of the method (see FIG. 14), as disclosed herein, can resolve a single overall chronological pressure profile into the distinct subprofiles, in accordance with their physiologic origin.
Expandable pressure sensing balloons, per embodiments of the technology, may assume one of at least two basic forms, type 1 or type 2. In balloon embodiments of type 1, which may be generally likened to a conventional party balloon, the pressure-sensing balloon is formed from or includes a compliant or elastic membrane. Accordingly, the surface area of the membrane expands or contracts as a function of the expansion of the balloon. The elasticity of the membrane determines various features of the balloon, as a whole, at different levels of expansion. Upon expansion, the balloon, if unconstrained, maintains a substantially constant or preferred form or shape, as determined by the mandrel upon which the balloon is formed. Upon expansion of the balloon from a minimal volume to its maximal volume, the membrane of the balloon maintains a level of tautness. Within the limits of elasticity of the compliant membrane, an increase in pressure during inflation results in a consequent expansion of volume. The balloon, on the whole may be considered partially compliant in that its shape responds to spatial constraints that it may encounter upon expansion or inflation, however the balloon does have a preferred or native shape, and such shape preference prevents a level of shape compliance or conformability such as that shown by a balloon of type 2.
In balloon embodiments of type 2, the expandable pressure-sensing balloon is formed from or includes a non-compliant, or non-elastic membrane, or a membrane that is substantially non-compliant or non-elastic. Accordingly, the surface area of the membrane does not expand or contract in accordance with the level of balloon expansion. Type 2 pressure-sensing balloons may be generally likened to a conventional Mylar® balloon. The inelasticity of the membrane determines various features of the balloon, as a whole, at different levels of expansion. Upon expansion of the balloon from a minimal volume to a level near its maximal volume, the membrane of the balloon is supple, and has a level of slackness. Expansion of a type 2 balloon occurs by way of outwardly directed smoothing of wrinkles and folds in the membrane. Deflation or compression of a type 2 balloon occurs by way of generally inwardly directed wrinkling and infolding. When a type 2 balloon is fully inflated (or substantially inflated) without being in a confining space, it assumes a preferred or native shape as determined by the geometry of the membrane or fabric of the balloon. However, in a state of partial inflation, the balloon, as a whole, is highly supple and conformable, broadly taking the shape as may be dictated by a confining space.
Expandable pressure sensing balloons, per embodiments of the technology, may also include features of both of the two basic forms, type 1 or type 2. In these embodiments, the membrane may include regions that are elastic (like type 1) and regions that are inelastic (like type 2). A balloon of this hybrid type would, as a whole, behave in a manner drawing from behavioral aspects of both type 1 and type 2 balloons, as described above. Further, type 1 balloons may be formed with a membrane that is not of a homogeneous composition or thickness. In such embodiments, regions of different thickness or composition could have varying degrees of elasticity, thus affecting the behavior of these regions during expansion of the balloon. In still other embodiments, elasticity of the membrane may have a bias or polarity that tends to permit elasticity in one or more directions, and tends to disallow elasticity in one or more other directions.
An aspect of the disclosed technology that is particularly advantageous in achieving a high resolution signal from which pressure profiles from particular physiologic sources (such as peritoneal pressure, respiratory rate, and cardiac rate, relative pulmonary tidal volume, cardiac output, relative cardiac output, and absolute cardiac stroke volume) may be monitored relates to adjusting and maintaining a balance of pressure on either side of the pressure interface represented by the membrane of the pressure sensing balloon. This balance of pressure may be referred to as a pressure differential of zero, or as a zero pressure gauge. Pressure impinging on the external face of balloon (facing the internal aspect of the bladder) is subject to change according to the physiology of the patient. Pressure on the internal face of the balloon (which is in fluid communication with the fluid column) is subject to degradation because of fluid leakage and imperfect seals.
Upon first insertion of the Foley type catheter, external pressure is typically applied to the fluid column and against the pressure interface to a first approximation of pressure being exerted on the pressure interface from within the bladder. Pressure signals, as measured across a pressure interface, have a maximal amplitude when the pressure differential is zero. Accordingly, the amplitude of a pressure signal can be used to tune the pressure being applied from the fluid column against the pressure interface. This process of applying an appropriate amount of pressure against the interface may be referred to as priming the fluid column or priming the balloon. Inasmuch as pressures on either side of the pressure interface may change, as described above, the fluid column may need to be reprimed or re-tuned, from time to time. The necessity of repriming can be monitored by testing small changes in pressure so as to achieve maximal amplitude of a pressure signal profile.
Embodiments of the disclosed system and method include automatic pressure tuning by a controller. Accordingly, the tuning system can detect the optimum target pressure and volume to inflate the balloon by monitoring sensed pressure signals and adding or removing air volume as needed. For example, upon insertion of the catheter, a pressure tuning circuit that regulates the balloon volume and pressure will inflate the balloon until it detects a physiologic-sourced pressure rate. Upon sensing that rate, the pressure tuning controller will add or subtract minute amounts of air in a routinized sequence until the amplitude of the sensed wave is greatest. The control feedback loop between the optimally tuned pressure (manifesting as balloon pressure and volume) and the sensed physiologic pressure profile iterates continuously and or as needed to ensure high fidelity measurement of the physiologic data. In some embodiments, automatic pressure tuning may be performed in the apparent background while the physiologic data is being transmitted and displayed; in other embodiments the system may suspend transmission of physiologic data during a pressure tuning sequence.
Embodiments of the disclosed technology include a gas delivery system that can deliver gas in a priming operation, whereby pressure can be applied to a fluid column proximal to the proximal-facing aspect of the pressure interface. A source of gas, such as compressed air or liquid is held in a storage tank. Using CO2 as an example, CO2 is controllably released from the storage tank through a pressure regulator that can step pressure in the tank (for example, pressure of about 850 psi) down to the range of about 1 psi to about 2 psi. Released gas passes through a filter and a pressure relief valve set at about 2.5 psi. The pressure relief valve is a safety feature that prevents flow through of gas at a level greater than 2.5 psi in the event of failure of the upstream regulator. CO2 exiting the pressure relief valve next passes through a first solenoid-controlled fill valve to enter the catheter line, ultimately filling the balloon that comprises the pressure-sensing interface. Pressure within the balloon is allowed to rise to a level as high as 30 mm Hg, whereupon the first solenoid-controlled valve closes. A second solenoid-controlled valve, distal to the first valve operates as a drain valve, which can release pressure from the catheter to a target pressure. Alternatively, the drain valve may be activated until a respiratory waveform is detected after which the balloon will be optimally primed and the valve will be closed. The drain valve may be subject to proportional control, operably based on voltage or pulse-width modulation (PWM), which allows a drain rate sufficiently slow that the target pressure is reached and the valve can be closed prior to overshoot. Alternatively, a peristaltic or other air pump may be utilized to fill the balloon with room air.
Intrabdominal pressure or bladder pressure, as sensed by an embodiment of the disclosed technology, may also be used to detect the level of patient movement (as may vary, for example, between substantially no movement to a high level of movement) and to report the movement level to a healthcare provider. A short burst of peaks and valleys in bladder pressure activity can serve as a proxy for body movement in that such a bladder pressure profile is a strong indicator that the patient is using their abdominal muscles, as, for example, to sit up or get out of bed. This embodiment may be of particular benefit for patients that are at risk of falling. In a patient that is a fall-risk, a healthcare provider may be notified that the patient is sitting up and respond accordingly. Alternatively, the device may be used to report inactivity of a patient and/or lack of patient movement.
Embodiments of the technology may also report patient movement in the detection or diagnosis of seizure disorder. In this embodiment, the pressure variations may trigger an EEG or recording equipment to allow for intense period of monitoring during an episode suspected of being a seizure. In addition, or alternatively, a pressure sensor, acoustic sensor or other sensors may be used to detect bowel activity, patient movement, seizure activity, patient shivering, frequency of coughing, severity of coughing, sleep quality, speech detection, patient compliance (movement or lack thereof), and may alert the healthcare provider that the patient has not moved and must be turned or rolled. This movement-related information may also be relayed to a hypothermia device, a drug delivery device or other device to control or mitigate seizure activity, shivering and/or coughing.
Embodiments of the technology may also automatically adjust intravenous fluid or drug infusion rates based on feedback from the cardiac output or respiratory rate sensed. In one such embodiment, a patient-controlled analgesia pump may be deactivated if a respiratory rate drops too low. Respiratory depression can be fatal in this group and this safeguard would prevent overdose. An automated feedback system may also be advantageous in a large volume resuscitation procedure, wherein fluid infusion can be tailored based on intraabdominal pressure to prevent abdominal compartment syndrome by sounding an alert and slowing infusion rates as the intraabdominal pressure rises. Yet another automated feedback feature may provide direct feedback to a ventilator system to provide the optimal pressure of ventilated gas. In the setting of increased abdominal pressure, typical ventilator settings do not provide sufficient respiration for the patient. An automated adjustment of the ventilator settings based on intraabdominal pressure feedback from this embodiment may advantageously provide for optimal patient ventilation. Embodiments of the technology may also be applied as a correction in the application or understanding of other diagnostic measurements. For example, central venous pressure may be dramatically distorted in the setting of elevated intraabdominal pressure. Providing direct access to these data by the central venous pressure reporting system allows for the automatic correction and accurate reporting of this critical physiologic parameter. Embodiments of the technology may also be used in a variety of other ways to automate therapy including infusion of fluids that may further include active agents, such as pressors or diuretics in response to increased or decreased cardiac output.
In some embodiments, the Foley type catheter is configured to report the presence of a water droplet or other obstruction in an air-filled lumen, and then handle or resolve the droplet. In a hypothermic setting, in particular, moisture in an air lumen can condense and form obstructive water droplets. Water droplets in an air-filled lumen (or air bubbles in a water-filled lumen) can disturb or complicate pressure signals due to the surface tension of the water. Accordingly, a pressure-transmission lumen in some embodiments of the disclosed technology may include a hydrophilic feature (such as a coating on the wall of the lumen itself, or a hydrophilic fiber running the length of the lumen) to wick moisture away from the lumen in order to maintain a continuous, uninterrupted air channel. In some embodiments, a hygroscopic composition (silica gel, for example) may be used in line with the air infusion line or within the air infusion lumen itself to capture water or humidity. In some embodiments, a hygroscopic composition may be included within the catheter so that the air infusion circuit need not be serviced to replace this material.
In some embodiments of the disclosed technology, air may also be intermittently (and automatically) infused and extracted into the pressure-sensing balloon so that the balloon is in a constant state of being optimally primed, as described in further detail above. In the case of the wicking fiber or hydrophilic coating in the lumen, the air extraction may also contribute to removing and trapping any water from the air line. In the instance of a liquid-filled lumen, a hydrophilic fiber or a hydrophilic coating on the inside of the pressure lumen will provide similar benefit in allowing this lumen to handle an air bubble. In this instance, an air bubble may distort the signal, but the air water interface surface tension is defused by a hydrophilic coating in the lumen of the catheter.
Additionally, a custom extrusion and lumen shape may also be used to prevent obstruction in the case of liquid and/or air-filled lumens. In some embodiments of the technology, for example, a Foley type catheter may have a lumen that is stellate in cross sectional profile. Such a lumen is generally immune from obstruction by a water droplet, as the droplet tends to cohere to itself and push away from the hydrophobic walls. This behavior tends to disallow filling of a cross-sectional space, and allows for an air channel to remain patent around the water droplet and communicate to the sensor. The same logic applies to an air bubble in water in a hydrophilic, stellate water lumen. In this instance the hydrophilic liquid will cling to the walls and allow for a continuous water column that excludes the air bubble to the center of the lumen. The same applies for a hydrophobic liquid in a hydrophobic lumen. In some embodiments, the catheter may include an air channel, and a sensor incorporated within the catheter itself or a fluid lumen that is capable of transmitting the pressure back to a sensor.
In some embodiments, the sensing Foley catheter may include a blood pressure sensing element that may take any of several forms. In one embodiment, a blood pressure sensing element includes a pressure delivery balloon 32 (either a separate, dedicated balloon or a balloon in fluid communication with a device retention balloon or a pressure sensing balloon) that can be optically analyzed as it is inflated to determine at which pressure the vessels within the bladder or urethra are blanched and blood flow is stopped. This approach provides a reading of the perfusion pressure of the tissue abutting the pressure delivery balloon, such reading reflective of both the systemic blood pressure and vascular resistance. This embodiment of a perfusion pressure device may be used to provide early detection or monitoring of a variety of acute or emergent medical conditions such as sepsis, shock, hemorrhage, and can be particularly advantageous in detecting these conditions at an early stage.
Other modalities may be used to detect that the tissue has been blanched or ischemic, as well, with the common methodological aspect being that of the intermittent inflation within the lumen, body cavity or bodily tissues to provide the compression of the vasculature. Embodiments of this device and associated methods may also be used to detect perfusion pressure in other areas of the body with an intermittently inflatable member and optical detection of blood flow or the presence of blood.
Tissue perfusion information may also be provided by way of sensors disposed on the shaft of the catheter such that they contact the urethral wall when the catheter is in place. These sensing technologies may include microdialysis, pyruvate, lactate, pO2, pCO2, pH, perfusion index, near-infrared spectroscopy, laser Doppler flowmetry, urethral capnography, and orthogonal polarization spectroscopy. Any of these tests may also be performed on the urine or the bladder wall itself to generate measurements of tissue perfusion.
Embodiments of a sensing Foley catheter have been used to collect data from a human subject (FIGS. 7-9) and from a pig (FIGS. 10-11). The human subject was a consenting and well-informed volunteer.
FIG. 7A shows an example of respiratory rate sensing data from a human subject, as provided by an embodiment of the sensing Foley catheter system. During this test period, the subject performs a respiratory sequence as follows: (1) breath being held at the end of an expiration, (2) valsalva, (3) normal respiration, (4) valsalva, and (5) breath being held at the end of an expiration. FIG. 7B shows a detailed portion of the respiratory profile of FIG. 8A, a portion of the period of normal respiration.
FIG. 8 shows an example of cardiac rate and relative cardiac output sensing data from a human subject, as provided by an embodiment of the sensing Foley catheter system, and an EKG trace as measured simultaneously and independently.
FIG. 9 shows data related to relative cardiac output sensing in a human leg raising exercise in which cardiac output increases, as demonstrated by an increased amplitude of the cardiac pulse.
The data shown in FIGS. 10 and 11 were derived from studies done with Yorkshire pigs under IACUC-approved protocols. FIG. 10 shows an example of peritoneal sensing data, with a focus on respiratory rate from a pig, as provided by an embodiment of the sensing Foley catheter system. FIG. 11 shows an example of pig study that demonstrates the capability of an embodiment of the sensing Foley catheter system to detect intra-abdominal hypertension. In this study, the peritoneal cavity was accessed with a 5 mm Tenamian trocar. The trocar was then attached to a 5 L bag of Lactated Ringers solution via a peristaltic pump, and the solution was infused at a rate of about 1 L per minute. Fluid flow was discontinued once a pressure of about 20 mmHg was obtained after which there was no net fluid flow in or out of the cavity.
FIG. 13 provides a flow diagram of an embodiment of the method of monitoring pressure as it occurs dynamically as waves of varied frequency and amplitude in the intraabdominal cavity, as detected from within the urinary bladder. Through the agency of a pressure interface, a high fidelity pressure profile is generated and transmitted proximally through a fluid column. More proximally, a pressure transducer converts the high fidelity pressure wave into a high fidelity electrical signal that is informative of pressure frequency and amplitude. The generated high fidelity electrical signal is then processed to yield data subsets that are reflective of components within the overall pressure profile, such subsets being attributable to particular physiologic sources, such as peritoneal pressure, respiratory rate, cardiac rate, relative cardiac output, and patient motion or activity.
Unless defined otherwise, all technical terms used herein have the same meanings as commonly understood by one of ordinary skill in the medical arts. Specific methods, devices, and materials are described in this application, but any methods and materials similar or equivalent to those described herein can be used in the practice of the present invention. While embodiments of the invention have been described in some detail and by way of illustrations, such illustrations are for purposes of clarity of understanding only, and are not intended to be limiting. Various terms have been used in the description to convey an understanding of the invention; it will be understood that the meaning of these various terms extends to common linguistic or grammatical variations thereof. Further, while some theoretical considerations may have been advanced in furtherance of providing an understanding of the technology, the appended claims to the invention are not bound by such theory. Moreover, any one or more features of any embodiment of the invention can be combined with any one or more other features of any other embodiment of the invention, without departing from the scope of the invention. Still further, it should be understood that the invention is not limited to the embodiments that have been set forth for purposes of exemplification, but is to be defined only by a fair reading of claims appended to the patent application, including the full range of equivalency to which each element thereof is entitled.
Patient Tracking
The present invention relates to monitoring patients to determine their whereabouts and correlating this information with their health status.
Prior to the present invention, location of a patient and their activity patterns has not been correlated with health status in order to provide an early indication of disease onset (or recurrence).
The present invention, then, allows for the use of wireless, satellite or other tracking mechanisms to determine the location of an individual. This location information, updated throughout the day, allows for a “time budget” to be provided to the patient and/or healthcare provider. The amount time spent in each location may then be analyzed to determine a change in behavior patterns that may provide early indication of illness.
In its simplest embodiment, the present invention provides a tracking device, ie a GPS unit, a cell phone, etc., and uses an algorithm to determine where a patient has been spending their time. In preferred embodiments, the patient will define locations, ie home, work, gym, etc. and the tracking device will then report when the patient is within these regions. The region may also be correlated to a map in order to more tightly define the region. This function will allow for better tracking as opposed to just drawing a broad circle around each of these regions and will allow for the patient to be reported as “At Work” even if their work spans many buildings. Preset definitions will also exist which may be correlated to a map and all of such destinations may be bucketed in the same “time budget” category. For example, a user may select a gym from a list of fitness centers then all fitness centers that are members of that gym will be registered as such. In addition the algorithm may be such that once a place (such as a fitness center) is identified as such based on GPS readings, a map may be consulted then all such fitness centers will be labeled as such without the need to define each fitness center individually. The same categorization and grouping applies for all time categories, including work, home (if a user owns two homes), gym, etc.
The time spent within each region may then be used to provide a time budget to patients and/or healthcare providers. The data may also, optionally, be anonymized and sent to a healthcare provider. In its ideal embodiment the actual tracking data (ie all locations that the patient has visited) will not be available to anyone other than the patient and may even be deleted from the device once the analysis has been performed and the time budget has been generated. In its preferred embodiment, as well, the device (which may consist of a single device or several devices interconnected) may wirelessly transmit the data to a healthcare provider after, the data has been analyzed and/or anonymized. Changes in movement patterns may then be analyzed by the healthcare provider (or an automated algorithm) and reported. A baseline period of healthy activity may also, preferably, be recorded and analyzed prior to the onset of monitoring so that a baseline may be established for comparison. Psychiatric and physical ailments may then be detected based on high-level locational data and where a user/patient is spending most of their time.
FIG. 14 details an example of an algorithm that may be used to report location of a user based on a device that they carry or wear. In this figure, the algorithm is focused on locating the user and reporting their location as one of four places: HOME, WORK, GYM, COMMUTE, OUT (here used as a catchall for anything other than the first four.
FIG. 15 shows a graphical representation of these data which may be provided to a user (so they can more accurately budget their time) or to a healthcare provider, supervisor, etc.

Claims (7)

What is claimed is:
1. A method of monitoring a health status of a patient via location tracking, comprising:
recording a patient's location information over a first period of time using a global positioning system (GPS) tracking device configured to be located with the patient, wherein the location information includes one or more locations each denoted as home, work, out, gym, or commute;
determining a baseline of locational data of the patient's location information via a processor and associating the baseline with healthy activities;
further tracking the patient's location information over a second period of time using the GPS tracking device configured to be located with the patient;
analyzing the patient's location information over the second period of time with an automated algorithm via the processor to determine movement patterns of the patient, wherein the location information includes at least two of home, work, out, gym, and commute; and
comparing the patient's location information over the second period of time against the baseline of locational data via the processor to monitor for a change in behavioral patterns relating to the movement patterns of the patient, where comparisons against the baseline of locational data are automatically analyzed via the processor for indications of an illness of the patient based on the baseline of locational data and a length of time of activity.
2. The method of claim 1 further comprising transmitting the patient's movement patterns to a health care provider located remotely from the patient.
3. The method of claim 1 wherein the one or more locations are defined by the patient as home, work, out, gym, or commute.
4. The method of claim 1 wherein the location information is correlated to a map.
5. The method of claim 1 wherein determining the baseline comprises generating a time budget based on the patient's location information.
6. The method of claim 1 wherein analyzing the patient's location information comprises determining an amount of time spent in each of the one or more locations.
7. The method of claim 1 wherein analyzing the behavioral patterns comprises grouping the movement patterns into time spent at the one or more locations.
US15/063,377 2011-03-07 2016-03-07 Method of monitoring health status of a patient Active 2033-05-18 US11241179B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US15/063,377 US11241179B2 (en) 2011-03-07 2016-03-07 Method of monitoring health status of a patient
US17/547,040 US11963773B2 (en) 2011-03-07 2021-12-09 Method of monitoring health status of a patient
US18/610,847 US20240215884A1 (en) 2011-03-07 2024-03-20 Method of monitoring health status of a patient

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161464619P 2011-03-07 2011-03-07
US201161628534P 2011-11-02 2011-11-02
US201261583258P 2012-01-05 2012-01-05
US13/414,011 US9655555B2 (en) 2011-03-07 2012-03-07 Sensing foley catheter
US15/063,377 US11241179B2 (en) 2011-03-07 2016-03-07 Method of monitoring health status of a patient

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/414,011 Continuation US9655555B2 (en) 2011-03-07 2012-03-07 Sensing foley catheter

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/547,040 Continuation US11963773B2 (en) 2011-03-07 2021-12-09 Method of monitoring health status of a patient

Publications (2)

Publication Number Publication Date
US20170100561A1 US20170100561A1 (en) 2017-04-13
US11241179B2 true US11241179B2 (en) 2022-02-08

Family

ID=46798547

Family Applications (7)

Application Number Title Priority Date Filing Date
US13/414,307 Active US9662058B2 (en) 2011-03-07 2012-03-07 Sensing Foley catheter
US13/414,011 Active US9655555B2 (en) 2011-03-07 2012-03-07 Sensing foley catheter
US15/063,377 Active 2033-05-18 US11241179B2 (en) 2011-03-07 2016-03-07 Method of monitoring health status of a patient
US15/583,730 Active US10952659B2 (en) 2011-03-07 2017-05-01 Sensing Foley catheter
US17/188,658 Active 2032-08-03 US11883174B2 (en) 2011-03-07 2021-03-01 Sensing foley catheter
US17/547,040 Active 2032-11-18 US11963773B2 (en) 2011-03-07 2021-12-09 Method of monitoring health status of a patient
US18/610,847 Pending US20240215884A1 (en) 2011-03-07 2024-03-20 Method of monitoring health status of a patient

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US13/414,307 Active US9662058B2 (en) 2011-03-07 2012-03-07 Sensing Foley catheter
US13/414,011 Active US9655555B2 (en) 2011-03-07 2012-03-07 Sensing foley catheter

Family Applications After (4)

Application Number Title Priority Date Filing Date
US15/583,730 Active US10952659B2 (en) 2011-03-07 2017-05-01 Sensing Foley catheter
US17/188,658 Active 2032-08-03 US11883174B2 (en) 2011-03-07 2021-03-01 Sensing foley catheter
US17/547,040 Active 2032-11-18 US11963773B2 (en) 2011-03-07 2021-12-09 Method of monitoring health status of a patient
US18/610,847 Pending US20240215884A1 (en) 2011-03-07 2024-03-20 Method of monitoring health status of a patient

Country Status (3)

Country Link
US (7) US9662058B2 (en)
EP (2) EP2683422B1 (en)
WO (1) WO2012122267A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11963773B2 (en) 2011-03-07 2024-04-23 Theranova, Llc Method of monitoring health status of a patient

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010523230A (en) 2007-04-05 2010-07-15 ベロメディックス,インク Automatic treatment system and method
US9603558B2 (en) 2008-08-15 2017-03-28 Theranova, Llc Methods and devices for the diagnosis and treatment of diabetes
US10369327B2 (en) * 2010-04-28 2019-08-06 Clph, Llc Catheters with lubricious linings and methods for making and using them
WO2012006625A2 (en) * 2010-07-09 2012-01-12 Velomedix, Inc. Method and apparatus for pressure measurement
US9962516B2 (en) 2010-09-09 2018-05-08 University Of Florida Research Foundation, Incorporated Context-sensitive flow interrupter and drainage outflow optimization system
WO2014099527A1 (en) 2012-12-17 2014-06-26 Theranova, Llc Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis
US10206802B2 (en) 2011-03-07 2019-02-19 Theranova, Llc Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis
EP2832290A4 (en) * 2012-03-27 2015-11-18 Suzhou Dawei Biopharma Ltd System and method for monitoring bladder and abdominal pressures, and bladder function recovery system
US20130309713A1 (en) * 2012-05-16 2013-11-21 David Ribble Pathogen detection systems and methods
KR101431051B1 (en) * 2012-12-31 2014-08-21 서강대학교산학협력단 Portable monitoring device for bladder pressure
US9456780B2 (en) 2013-02-07 2016-10-04 Hill-Rom Services, Inc. Dynamic therapy delivery system
DE102013102085A1 (en) * 2013-03-04 2014-09-04 Andromeda Medizinische Systeme Gmbh Device for measuring pressure in a fluid
CA2897940A1 (en) * 2013-03-15 2014-09-25 C.R. Bard, Inc. Temperature sensing catheter
JP6436402B6 (en) * 2013-06-27 2019-01-30 セラノーヴァ,エルエルシー Sensing Foley catheter
DE102013014685B4 (en) * 2013-09-05 2018-01-04 Universität Stuttgart Urokatheter
WO2015066617A1 (en) 2013-11-01 2015-05-07 Medtronic Xomed, Inc. Foley catheter with ring electrodes
JP2017511480A (en) 2014-03-31 2017-04-20 ユニヴァーシティー オブ ユタ リサーチ ファウンデーション Liquid analysis device and related systems and methods
US9775555B2 (en) 2014-05-28 2017-10-03 Joanmarie Dietz PELLEGRINI Inter-ureter signaling device
US9579059B2 (en) * 2014-05-28 2017-02-28 Joanmarie Dietz PELLEGRINI Inter-ureter signaling device
CA2992263A1 (en) * 2014-06-25 2015-12-30 Canary Medical Inc. Devices, systems and methods for using and monitoring tubes in body passageways
CN104068843B (en) * 2014-07-09 2017-01-11 江苏苏云医疗器材有限公司 Portable bladder pressure training device
EP3197349B1 (en) * 2014-09-28 2023-07-19 Potrero Medical, Inc. Systems, devices and methods for sensing physiologic data and draining and analyzing bodily fluids
WO2016073945A1 (en) 2014-11-07 2016-05-12 Respirix, Inc. Devices and methods for monitoring physiologic parameters
CN117085181A (en) * 2014-12-19 2023-11-21 比奥斯株式会社 Organ for transplantation and organ structure
WO2016154457A1 (en) * 2015-03-24 2016-09-29 University Of Iowa Research Foundation Bladder health monitoring systems and related methods and devices
EP3294135A4 (en) 2015-05-12 2019-01-09 Mir Imran Device, system and methods for measurement of pressures in the urinary tract
US10918827B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Catheter device and method for inducing negative pressure in a patient's bladder
US11541205B2 (en) 2015-07-20 2023-01-03 Roivios Limited Coated urinary catheter or ureteral stent and method
US10493232B2 (en) 2015-07-20 2019-12-03 Strataca Systems Limited Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
MA42500A (en) * 2015-07-20 2018-05-30 Strataca Systems Llc PROBING DEVICE AND METHOD FOR INDUCING NEGATIVE PRESSURE IN THE BLADDER OF A PATIENT
US11229771B2 (en) 2015-07-20 2022-01-25 Roivios Limited Percutaneous ureteral catheter
US10512713B2 (en) 2015-07-20 2019-12-24 Strataca Systems Limited Method of removing excess fluid from a patient with hemodilution
US11040180B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Systems, kits and methods for inducing negative pressure to increase renal function
US11040172B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US12064567B2 (en) 2015-07-20 2024-08-20 Roivios Limited Percutaneous urinary catheter
US10765834B2 (en) 2015-07-20 2020-09-08 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10926062B2 (en) 2015-07-20 2021-02-23 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
AU2016324320B2 (en) * 2015-09-18 2019-08-08 Eric A. WASHINGTON Urinary collection system and procedure for decreasing catheter-associated bacteriuria
CN113598720B (en) * 2015-09-25 2024-08-23 C·R·巴德股份有限公司 Catheter assembly with monitoring function
US10206575B2 (en) * 2015-12-04 2019-02-19 Adil Al-Mayah Apparatus and method for using internal inclusion for mechanical characterization of soft materials
EP3424543B1 (en) * 2016-03-02 2021-05-05 Tsukada Medical Research Co., Ltd. Bladder urodynamic measurement apparatus
EP3474769B1 (en) * 2016-06-23 2023-08-23 Nellcor Puritan Bennett Ireland Unlimited Company Pressure monitoring apparatus and a catheter for monitoring pressure in a liquid
US20180235543A1 (en) * 2017-02-17 2018-08-23 Boston Scientific Scimed, Inc. Medical device with pressure sensor
US20180256161A1 (en) * 2017-03-08 2018-09-13 Covidien Lp Surgical instruments including sensors
US10687811B2 (en) * 2017-03-08 2020-06-23 Covidien Lp Surgical instruments including sensors
JP6861059B2 (en) * 2017-03-15 2021-04-21 オムロン株式会社 Blood pressure measuring device with sound detection function and blood pressure measuring method
US10219981B2 (en) * 2017-03-31 2019-03-05 Integra Lifesciences Switzerland Sàrl Fluid containers and systems and methods for detecting a fluid level therein
GB201705379D0 (en) 2017-04-04 2017-05-17 Smiths Medical Int Ltd Medico-surgical tubes
KR101786981B1 (en) * 2017-04-25 2017-10-18 한국과학기술원 Catheter-guided miniaturized wireless viscera compliance sensor system
US10799131B2 (en) 2017-06-03 2020-10-13 Sentinel Medical Technologies, LLC Catheter for monitoring intrauterine pressure to protect the fallopian tubes
US11045143B2 (en) 2017-06-03 2021-06-29 Sentinel Medical Technologies, LLC Catheter with connectable hub for monitoring pressure
US10813589B2 (en) * 2017-06-03 2020-10-27 Sentinel Medical Technologies, LLC Catheter for monitoring uterine contraction pressure
US11045128B2 (en) 2017-06-03 2021-06-29 Sentinel Medical Technologies, LLC Catheter for monitoring intra-abdominal pressure
US11185245B2 (en) 2017-06-03 2021-11-30 Sentinel Medical Technologies, Llc. Catheter for monitoring pressure for muscle compartment syndrome
US11179516B2 (en) 2017-06-22 2021-11-23 Baxter International Inc. Systems and methods for incorporating patient pressure into medical fluid delivery
FR3068234B1 (en) * 2017-06-30 2021-10-29 Adp Advanced Perfusion Diagnostics SYSTEM AND METHOD FOR MONITORING TISSUE INFUSION
EP3672677A1 (en) 2017-08-25 2020-07-01 Strataca Systems Limited Indwelling pump for facilitating removal of urine from the urinary tract
US11395616B2 (en) 2017-09-07 2022-07-26 WSA Medical Ventures, LLC Catheter assemblies, oxygen-sensing assemblies, and related methods
US11660032B2 (en) 2017-09-07 2023-05-30 SWSA Medical Ventures, LLC Catheter assemblies, oxygen-sensing assemblies, and related methods
CN112165970A (en) * 2018-05-22 2021-01-01 C·R·巴德股份有限公司 Catheter insertion system and method of use
WO2019246126A1 (en) 2018-06-19 2019-12-26 Potrero Medical, Inc. Equipment adaptor assembly and equipment stand
JP7314252B2 (en) 2018-08-10 2023-07-25 シー・アール・バード・インコーポレーテッド Automatic urine volume measurement system
GB201818696D0 (en) 2018-11-15 2019-01-02 Smiths Medical International Ltd Medico-surgical tubes
US11672457B2 (en) 2018-11-24 2023-06-13 Sentinel Medical Technologies, Llc. Catheter for monitoring pressure
US11779263B2 (en) 2019-02-08 2023-10-10 Sentinel Medical Technologies, Llc. Catheter for monitoring intra-abdominal pressure for assessing preeclampsia
US11529449B2 (en) 2019-04-15 2022-12-20 Medtronic, Inc. Medical device dislodgment detection
US11730385B2 (en) 2019-08-08 2023-08-22 Sentinel Medical Technologies, LLC Cable for use with pressure monitoring catheters
US11559257B2 (en) * 2019-12-23 2023-01-24 Covidien Lp Catheter insert including one or more sensors
US11617543B2 (en) 2019-12-30 2023-04-04 Sentinel Medical Technologies, Llc. Catheter for monitoring pressure
WO2021142142A1 (en) 2020-01-07 2021-07-15 Bard Access Systems, Inc. Diagnostic systems and methods including temperature-sensing vascular devices
US11865270B2 (en) 2020-01-16 2024-01-09 Starling Medical, Inc. Bodily fluid management system
US11717642B2 (en) 2020-04-24 2023-08-08 Covidien Lp Catheter including one or more sensors
US12083261B2 (en) 2020-06-05 2024-09-10 C. R. Bard, Inc. Automated fluid output monitoring
US11703365B2 (en) 2020-07-14 2023-07-18 C. R. Bard, Inc. Automatic fluid flow system with push-button connection
US11744498B2 (en) 2020-07-17 2023-09-05 Covidien Lp Catheter system
US12055249B2 (en) 2020-07-21 2024-08-06 C. R. Bard, Inc. Automatic fluid flow system with retractable connection
US11864893B2 (en) 2020-09-04 2024-01-09 Covidien Lp Oxygen sensor calibration
US11931151B2 (en) 2020-12-22 2024-03-19 C. R. Bard, Inc. Automated urinary output measuring system
EP4275593A1 (en) 2022-05-09 2023-11-15 Wellspect AB Disposable medical device assembly with sensor
CN218651767U (en) * 2022-08-31 2023-03-21 湖南省华芯医疗器械有限公司 Ureteral sheath and equipment inserted into human ureter

Citations (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3326207A (en) 1964-07-10 1967-06-20 James J Egan Electrocardiac instrument for testing unborn infants
US4077394A (en) 1976-08-25 1978-03-07 Mccurdy Martin D Integral pressure sensor probe for a cardiac assistance device
US4413633A (en) 1981-06-01 1983-11-08 Yanda Roman L Method and apparatus for monitoring body conditions
US4502490A (en) 1980-10-28 1985-03-05 Antec Systems Limited Patient monitoring equipment, probe for use therewith, and method of measuring anesthesia based on oesophagal contractions
US4600015A (en) 1980-10-28 1986-07-15 Antec Systems Limited Patient monitoring apparatus and method
US4712566A (en) 1985-01-10 1987-12-15 Radisensor Ab Device for recording physiological pressures
US4841981A (en) 1986-03-07 1989-06-27 Terumo Corporation Catheters for measurement of cardiac output and blood flow velocity
US5035231A (en) 1987-04-27 1991-07-30 Olympus Optical Co., Ltd. Endoscope apparatus
US5048532A (en) 1989-09-18 1991-09-17 State University Of New York Method and apparatus for measuring blood pressure
US5133358A (en) 1990-09-07 1992-07-28 Becton, Dickinson And Company Apparatus for rezeroing an in vivo pressure sensor and method for rezeroing
US5158529A (en) 1990-03-29 1992-10-27 Aisin Seiki Kabushiki Kaisha Pumping device for operating an intra-aortic balloon
US5171299A (en) 1991-08-02 1992-12-15 Baxter International Inc. Balloon catheter inflation pressure and diameter display apparatus and method
US5220927A (en) 1988-07-28 1993-06-22 Bsd Medical Corporation Urethral inserted applicator for prostate hyperthermia
US5240675A (en) 1992-09-24 1993-08-31 Wilk Peter J Method for cleaning endoscope
US5257630A (en) 1992-05-15 1993-11-02 Thermometrics, Inc. Pressure sensing probe with calibration capability
US5263485A (en) 1989-09-18 1993-11-23 The Research Foundation Of State University Of New York Combination esophageal catheter for the measurement of atrial pressure
US5344435A (en) 1988-07-28 1994-09-06 Bsd Medical Corporation Urethral inserted applicator prostate hyperthermia
US5389217A (en) 1994-04-28 1995-02-14 Biomedical Sensors Ltd. Measurement of bladder oxygen
US5413558A (en) 1991-09-09 1995-05-09 New York University Selective aortic perfusion system for use during CPR
US5425362A (en) 1993-07-30 1995-06-20 Criticare Fetal sensor device
US5427114A (en) 1993-08-19 1995-06-27 Fiberoptic Sensor Technologies, Inc. Dual pressure sensing catheter
US5431628A (en) 1992-09-29 1995-07-11 Millar Instruments, Inc. Pressure-sensing diagnostic catheter
US5433216A (en) 1993-06-14 1995-07-18 Mountpelier Investments, S.A. Intra-abdominal pressure measurement apparatus and method
US5517998A (en) 1994-01-24 1996-05-21 Medamicus, Inc. Closed loop pressure determination system and method for fiber optic pressure transducer system
US5570671A (en) 1989-09-18 1996-11-05 The Research Foundation Of State University Of New York Method for positioning esophageal catheter for determining pressures associated with the left atrium
US5573007A (en) 1994-08-08 1996-11-12 Innerspace, Inc. Gas column pressure monitoring catheters
US5652570A (en) * 1994-05-19 1997-07-29 Lepkofker; Robert Individual location system
US5678570A (en) 1995-04-14 1997-10-21 The University Of North Carolina At Chapel Hill Method of treating cardiac arrest
US5788642A (en) 1995-06-19 1998-08-04 Becton, Dickinson And Company In vivo rezero apparatus for a pressure transducer
US5865801A (en) 1995-07-18 1999-02-02 Houser; Russell A. Multiple compartmented balloon catheter with external pressure sensing
US5902248A (en) 1996-11-06 1999-05-11 Millar Instruments, Inc. Reduced size catheter tip measurement device
US5916153A (en) 1997-10-27 1999-06-29 Rhea, Jr.; W. Gardner Multifunction catheter
US5921935A (en) 1989-09-18 1999-07-13 The Research Foundation Of State University Of New York Method and apparatus utilizing heart sounds for determining pressures associated with the left atrium
US5984879A (en) 1996-09-03 1999-11-16 Clinical Innovation Associates, Inc. Intrauterine pressure catheter device
US6001600A (en) 1996-12-20 1999-12-14 Smithkline Beecham Plc DNA encoding tests polypeptides
US6002982A (en) * 1996-11-01 1999-12-14 Fry; William R. Sports computer with GPS receiver and performance tracking capabilities
US6083215A (en) 1995-07-17 2000-07-04 Milavetz; James J. Method and apparatus for antegrade coronary perfusion
US6149578A (en) 1999-02-04 2000-11-21 My-Tech, Inc. Piston-action intra-aortic coronary assist device
US20010020162A1 (en) 1998-10-19 2001-09-06 Brian Mosel Urinary incontinence diagnostic system
US6287253B1 (en) 1999-06-25 2001-09-11 Sabolich Research & Development Pressure ulcer condition sensing and monitoring
US6299583B1 (en) 1998-03-17 2001-10-09 Cardiox Corporation Monitoring total circulating blood volume and cardiac output
US20010035046A1 (en) 1999-06-24 2001-11-01 Jonathan Williams Balloon catheter leak detection method and apparatus
US6322514B1 (en) 2000-03-13 2001-11-27 Instrumentarium Corporation Method for determining cardiac characteristics of subject
US20010049470A1 (en) * 2000-01-19 2001-12-06 Mault James R. Diet and activity monitoring device
US20020066458A1 (en) 1998-04-21 2002-06-06 Aliberto Anthony C. Central venous catheter with heat exchange membrane
US20020077680A1 (en) 2000-12-15 2002-06-20 Alsius Temperature sensor adapter for foley catheters
US6434418B1 (en) 2000-04-12 2002-08-13 Randall H. Neal Apparatus for measuring intrauterine pressure and fetal heart rate and method for using same
US6447462B1 (en) 2000-02-15 2002-09-10 Clinical Innovation Associates, Inc. Urodynamic catheter and methods of fabrication and use
US6511412B1 (en) 1998-09-30 2003-01-28 L. Vad Technology, Inc. Cardivascular support control system
US6616597B2 (en) 2000-12-12 2003-09-09 Datascope Investment Corp. Intra-aortic balloon catheter having a dual sensor pressure sensing system
US6646906B2 (en) 2000-08-31 2003-11-11 Micron Technology, Inc. Methods of reading ferroelectric memory cells
US6666828B2 (en) 2001-06-29 2003-12-23 Medtronic, Inc. Catheter system having disposable balloon
US20040097813A1 (en) 2002-11-19 2004-05-20 Jonathan Williams Method and device for correcting in -vivo sensor drift
US20040116782A1 (en) * 2002-12-17 2004-06-17 International Business Machines Corporation Behavior based life support with abstract behavior patterns
US20040167415A1 (en) 2003-02-24 2004-08-26 Plc Systems Inc. Method and system for prevention of radiocontrast nephropathy
US20040236395A1 (en) 2001-02-09 2004-11-25 Medtronic, Inc. System and method for placing an implantable medical device within a body
US20050075531A1 (en) 2003-10-07 2005-04-07 Loeb Marvin P. Devices and methods for non-invasively improving blood circulation
US6912416B2 (en) 2001-07-18 2005-06-28 Peter L. Rosenblatt Detecting or preventing tissue damage
US20050148828A1 (en) * 2003-12-30 2005-07-07 Kimberly-Clark Worldwide, Inc. RFID system and method for tracking environmental data
US6916283B2 (en) 2001-06-29 2005-07-12 Ethicon, Inc. System and method for assessing urinary function
US6918924B2 (en) 2000-04-06 2005-07-19 Innercool Therapies, Inc. Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid
US6931276B2 (en) 2002-04-29 2005-08-16 Tomi Streng Method and device for use in micturition studies
US20050209524A1 (en) 2004-03-10 2005-09-22 General Electric Company System and method for receiving and storing information pertaining to a patient
US20050288603A1 (en) 2004-06-24 2005-12-29 Goping Ing H F Method for obtaining and displaying urethral pressure profiles
US7004899B2 (en) 2001-06-29 2006-02-28 Ethicon, Inc. System and method for assessing urinary function
US20060100743A1 (en) 2004-04-23 2006-05-11 Renal Diagnostic Inc. Automated non-invasive real-time acute renal failure detection system
US20060116601A1 (en) 2003-02-17 2006-06-01 Raymond Glocker Methods and apparatus for measuring pressure profiles
WO2006060248A2 (en) 2004-12-03 2006-06-08 Wolfe Tory Medical, Inc. Pressure and temperature monitoring balloon catheter
US20060122864A1 (en) * 2004-12-02 2006-06-08 Gottesman Janell M Patient management network
US20060178571A1 (en) 2001-06-01 2006-08-10 Diametrics Medical Limited Apparatus and method for determining organ perfusion
US7112177B2 (en) 2003-03-04 2006-09-26 Wolfe Tory Medical, Inc. Apparatus for monitoring intra-abdominal pressure
US20060234383A1 (en) 2003-02-19 2006-10-19 Nigel Gough Tissue assessment
US20060275907A1 (en) 2003-05-09 2006-12-07 Cgs Sensortechnik Gmbh Device for measuring pressure
US20060287604A1 (en) 2005-06-17 2006-12-21 Hickey Donald D Method of determining cardiac indicators
US20060284732A1 (en) * 2003-10-23 2006-12-21 George Brock-Fisher Heart monitor with remote alarm capability
US7154398B2 (en) * 2003-01-06 2006-12-26 Chen Thomas C H Wireless communication and global location enabled intelligent health monitoring system
WO2007018963A2 (en) 2005-07-14 2007-02-15 C.R. Bard, Inc. Intra-abdominal pressure monitoring system
US20070038143A1 (en) 2003-03-04 2007-02-15 Christensen Mark A Medical valve and method to monitor intra-abdominal pressure
US20070083126A1 (en) 2005-09-27 2007-04-12 Angiometrx, Inc. Apparatus & method for determining physiologic characteristics of body lumens
US20070197881A1 (en) * 2006-02-22 2007-08-23 Wolf James L Wireless Health Monitor Device and System with Cognition
US20070219823A1 (en) * 2006-03-17 2007-09-20 Warner Adrian F Patient monitoring device for remote patient monitoring
US20070225584A1 (en) 2004-04-19 2007-09-27 University Of Florida Researouchfoundation, Inc. Novel Catheter Sensor
US20070255167A1 (en) 2004-03-01 2007-11-01 Wolfe Tory Medical, Inc. Apparatus for monitoring intra-abdominal pressure
US20070270699A1 (en) 2004-01-08 2007-11-22 Dialog Devices Limited System or Method for Assessing a Subject's Peripheral Blood Circulation
US20080076971A1 (en) * 2006-08-31 2008-03-27 Geoffrey Clapp Health related location awareness
US7381190B2 (en) 2003-03-10 2008-06-03 Wolfe Tory Medical, Inc. Intra-abdominal pressure monitoring urinary catheter
US20080140000A1 (en) 2006-12-07 2008-06-12 Cardiac Pacemakers, Inc. Device and method for modulating renal function
US20080164998A1 (en) * 2007-01-05 2008-07-10 Siemens Medical Solutions Usa, Inc. Location Sensitive Healthcare Task Management System
WO2008097609A2 (en) 2007-02-07 2008-08-14 Massachusetts Institute Of Technology Methods and devices for sensing tissues and tissue compartments
WO2008103625A2 (en) 2007-02-21 2008-08-28 C.R. Bard, Inc. Acs therapy system
WO2008117574A1 (en) 2007-03-26 2008-10-02 Jms Co., Ltd. Balloon for measuring pressure related to oral cavity and method for producing the same
US20080262418A1 (en) 2007-04-05 2008-10-23 Daniel Rogers Burnett Automated Therapy System and Method
US20090062686A1 (en) * 2007-09-05 2009-03-05 Hyde Roderick A Physiological condition measuring device
US20090076573A1 (en) 2007-07-09 2009-03-19 Daniel Rogers Burnett Hypothermia Devices and Methods
WO2009055435A1 (en) 2007-10-23 2009-04-30 C. R. Bard, Inc. Continuous intra-abdominal pressure monitoring system
US20090120439A1 (en) 2007-11-08 2009-05-14 Fred Goebel Method of triggering a ventilator
US20090306588A1 (en) 2008-06-06 2009-12-10 Ethicon, Inc. Balloon catheter systems and methods for treating uterine disorders
US20090312740A1 (en) 2005-12-27 2009-12-17 Acist Medical Systems, Inc. Balloon Inflation Device
US20100010552A1 (en) 2008-07-10 2010-01-14 Texas Heart Institute Method and system for temperature analysis to provide an early marker of congestive heart failure progress that precedes a patient's symptoms
US20100030190A1 (en) 2008-06-24 2010-02-04 Singh Vijay P Gastroduodenal balloon tubes and methods for use in localized hypothermia
US20100049095A1 (en) * 2008-03-14 2010-02-25 Stresscam Operations & Systems, Ltd. (c/o PHD Associates) Assessment of medical conditions by determining mobility
US20100056872A1 (en) * 2008-08-29 2010-03-04 Philippe Kahn Sensor Fusion for Activity Identification
US20100057046A1 (en) 2008-09-03 2010-03-04 Keimar, Inc Systems for characterizing physiologic parameters and methods for use therewith
US20100121220A1 (en) 2007-02-21 2010-05-13 C. R. Bard, Inc Renal monitor
US20100121159A1 (en) 2008-11-07 2010-05-13 Daniel Rogers Burnett Devices and Methods for Monitoring Core Temperature and an Intraperitoneal Parameter
US20100130880A1 (en) 2007-04-16 2010-05-27 Urodynamix Technologies Ltd. Apparatus and methods for monitoring blood flow in the prostrate gland
US20100204765A1 (en) 2009-02-06 2010-08-12 Hall Gregory W Method and Apparatus for Inducing Therapeutic Hypothermia
US20100228148A1 (en) 2005-11-15 2010-09-09 Kyoung-Hun Kim Novel Quantitative and Qualitative Analysis Apparatus for Measuring the Body Fluid
US20100234693A1 (en) * 2009-03-16 2010-09-16 Robert Bosch Gmbh Activity monitoring device and method
US20100286559A1 (en) 2006-08-23 2010-11-11 Ilan Paz Diagnostic methods and systems based on urine analysis
US20110040211A1 (en) 2005-10-18 2011-02-17 Pneumoflex Systems, Llc Oral-esophageal-gastric device to diagnose reflux and/or emesis
US20110046653A1 (en) 2005-10-18 2011-02-24 PNEUMOFLEX SYSTEMS, LLC, State of Incorporation: Florida Oral-esophageal-gastric device with esophageal cuff to reduce gastric reflux and/or emesis
US20110071482A1 (en) 2009-01-28 2011-03-24 Selevan James R Devices and methods for signaling when action is due in relation to a medical device
US20110082554A1 (en) 2009-10-02 2011-04-07 Glazer Paul A Devices for delivering spinal disc implants
US20110133927A1 (en) * 2008-08-14 2011-06-09 Humphrey Christopher A Environmental risk management system and method
US20110144423A1 (en) 2005-05-20 2011-06-16 Neotract, Inc. Median Lobe Retraction Apparatus and Method
US20110184247A1 (en) * 2010-01-25 2011-07-28 Contant Olivier M Comprehensive management of human health
US8052671B2 (en) 2004-10-11 2011-11-08 Abviser Medical, Llc Intra-abdominal pressure monitoring device and method
US8075499B2 (en) * 2007-05-18 2011-12-13 Vaidhi Nathan Abnormal motion detector and monitor
US20120029390A1 (en) * 2010-07-30 2012-02-02 John Colborn Seizure detection using coordinate data
US8116838B2 (en) 2007-11-27 2012-02-14 Carnegie Mellon University Medical device for diagnosing pressure ulcers
US20120095537A1 (en) 2010-02-08 2012-04-19 Hall Gregory W Method and Apparatus for Inducing Therapeutic Hypothermia
WO2012122267A1 (en) 2011-03-07 2012-09-13 Theranova, Llc Sensing foley catheter
US8301575B2 (en) * 2007-07-23 2012-10-30 Commissariat A L'energie Atomique Method and device for the recognition of the position or movement of a device or a person
US8396537B2 (en) 2009-04-20 2013-03-12 Mindray Ds Usa, Inc. Method and system to measure ECG and respiration
US20130231584A1 (en) 2010-07-09 2013-09-05 Daniel Rogers Burnett Method and apparatus for pressure measurement
US8979774B2 (en) * 2009-01-13 2015-03-17 Robert Bosch Gmbh Activity monitoring device and method
US9507027B2 (en) * 2010-08-06 2016-11-29 Qualcomm Incorporated Determining location of a target device based on relative change in location information

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1444565A (en) 1920-09-01 1923-02-06 Smith John Ciceri Gauge
US3730209A (en) 1971-06-02 1973-05-01 Kendall & Co Vent for liquid drainage system
US3851650A (en) 1972-06-06 1974-12-03 Kendall & Co Closed drainage system with double lumen tube
US4343316A (en) * 1980-05-16 1982-08-10 C. R. Bard, Inc. Electronic urine flow monitor
US4535786A (en) 1983-07-25 1985-08-20 Kater John A R Measurement of body fluid chemistry
US5222008A (en) 1988-03-17 1993-06-22 Canon Kabushiki Kaisha Audio signal processing apparatus which may display remaining recording or reproducing capacity
US5476434A (en) 1992-05-27 1995-12-19 Kalb; Irvin M. Female incontinence device including electronic sensors
DE4306478A1 (en) 1993-03-02 1994-09-08 Wolfgang Dr Wagner Drainage device, in particular pleural drainage device, and drainage method
US20020055731A1 (en) 1997-10-24 2002-05-09 Anthony Atala Methods for promoting cell transfection in vivo
US6673022B1 (en) 1999-08-20 2004-01-06 Innerspace Medical, Inc. Gas column pressure monitoring catheters
US6343225B1 (en) 1999-09-14 2002-01-29 Implanted Biosystems, Inc. Implantable glucose sensor
DE10001845C2 (en) 2000-01-18 2002-03-07 Norbert Egger Fitness device in the form of an item of clothing
DE60234816D1 (en) 2001-03-01 2010-02-04 David A Watson THE GROWING PREVENTIVE DWELL CATHETER ARRANGEMENT
US7311690B2 (en) * 2002-02-25 2007-12-25 Novashunt Ag Implantable fluid management system for the removal of excess fluid
US7033336B2 (en) 2002-03-29 2006-04-25 Gore Enterprise Holdings, Inc. Proximal catheter assembly having a relief valve
US20040082859A1 (en) 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
DE50304300D1 (en) 2002-09-25 2006-08-31 Prospective Concepts Ag FITNESS DEVICE
GB0224986D0 (en) 2002-10-28 2002-12-04 Smith & Nephew Apparatus
WO2004087014A2 (en) 2003-03-28 2004-10-14 Gi Dynamics, Inc. Anti-obesity devices
EP1638487A2 (en) * 2003-05-28 2006-03-29 Medcool, Inc. Methods and apparatus for thermally activating a console of a thermal delivery system
US20080119703A1 (en) * 2006-10-04 2008-05-22 Mark Brister Analyte sensor
CN1859935B (en) 2003-12-22 2011-07-20 美德乐控股公司 Drainage apparatus and method
WO2005067790A1 (en) 2004-01-16 2005-07-28 Compumedics Ltd Method and apparatus for ecg-derived sleep disordered breathing monitoring, detection and classification
US20050192626A1 (en) 2004-01-30 2005-09-01 Nmt Medical, Inc. Devices, systems, and methods for closure of cardiac openings
US8157775B2 (en) 2004-03-10 2012-04-17 Haemonetics Corporation Postoperative fluid monitoring and alert system
EP1758636A2 (en) 2004-04-02 2007-03-07 The Regents Of The University Of California Device and systems for the intermittent drainage of urine and other biological fluids
GB0424046D0 (en) 2004-10-29 2004-12-01 Smith & Nephew Apparatus
US7462158B2 (en) 2004-05-07 2008-12-09 Amit Mor Bone-growth stimulator
GB0414222D0 (en) * 2004-06-24 2004-07-28 Univ Cardiff pH sensor
US7727222B2 (en) * 2004-09-09 2010-06-01 Plc Medical Systems, Inc. Patient hydration system with taper down feature
US7938817B2 (en) 2004-09-09 2011-05-10 Plc Medical Systems, Inc. Patient hydration system and method
US7850704B2 (en) 2004-09-27 2010-12-14 Theranova, Llc Method and apparatus for anchoring implants
WO2006044621A2 (en) 2004-10-15 2006-04-27 The Regents Of The University Of California Improved drainage system
US7717869B2 (en) 2005-02-18 2010-05-18 Eischco, Inc. Pressure maintained inflatable boot
US7739907B2 (en) 2006-11-29 2010-06-22 Future Path Medical Llc Container for physiological fluids
US8813551B2 (en) 2005-04-10 2014-08-26 Future Path Medical Holding Co. Llc Device that accurately measures physiological fluid flow
US7892217B2 (en) 2005-04-10 2011-02-22 Future Path Medical, Llc Variable cross-section containment structure liquid measurement device
CA2611492C (en) 2005-06-10 2014-05-13 The Ohio Willow Wood Company Prosthetic device utilizing electric vacuum pump
CA2614366C (en) 2005-07-05 2013-10-15 C.R. Bard, Inc. Multi-functional and modular urine collection system
US7931630B2 (en) 2005-07-05 2011-04-26 C. R. Bard, Inc. Multi-functional and modular urine collection system
US20100137743A1 (en) 2005-07-05 2010-06-03 C. R. Bard, Inc. Multi-functional and modular urine collection system
US20070121196A1 (en) 2005-09-29 2007-05-31 The General Hospital Corporation Method and apparatus for method for viewing and analyzing of one or more biological samples with progressively increasing resolutions
US7733224B2 (en) * 2006-06-30 2010-06-08 Bao Tran Mesh network personal emergency response appliance
US20070093697A1 (en) * 2005-10-21 2007-04-26 Theranova, Llc Method and apparatus for detection of right to left shunting in the cardiopulmonary vasculature
US8221310B2 (en) 2005-10-25 2012-07-17 Voyage Medical, Inc. Tissue visualization device and method variations
US7597101B2 (en) 2006-01-17 2009-10-06 Theranova, Llc Method and apparatus for personal isolation and/or protection
US7666144B2 (en) 2006-02-21 2010-02-23 Board Of Trustees Operating Michigan State University Methods and apparatus for determining cardiac output and left atrial pressure
WO2007100846A2 (en) 2006-02-28 2007-09-07 Emphasys Medical, Inc. Endoscopic tool
US7955365B2 (en) 2006-04-07 2011-06-07 Medtronic Vascular, Inc. Closed loop catheter photopolymerization system and method of treating a vascular condition
US20090187164A1 (en) 2006-05-03 2009-07-23 Rowe Philip S Nasogastric tube placement and monitoring system
US7955282B2 (en) 2006-09-19 2011-06-07 Hong-Jik Doo System and device to sculpt an individual's body
US7763033B2 (en) 2006-10-18 2010-07-27 Interlace Medical, Inc. System and methods for preventing intravasation during intrauterine procedures
EP2076172A4 (en) 2006-10-27 2012-03-21 Aretais Inc Use of coherent raman techniques for medical diagnostic and therapeutic purposes, and calibration techniques for same
JP5295119B2 (en) 2006-11-16 2013-09-18 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Feeding tubes, especially for complete parenteral nutrition and / or pharmaceutical administration
US20080320030A1 (en) * 2007-02-16 2008-12-25 Stivoric John M Lifeotype markup language
US9295395B2 (en) 2007-03-02 2016-03-29 Art Healthcare Ltd. Interactive NGT system
US9259233B2 (en) 2007-04-06 2016-02-16 Hologic, Inc. Method and device for distending a gynecological cavity
WO2008141470A1 (en) 2007-05-22 2008-11-27 Medela Holding Ag Drainage tube unit
WO2009010975A1 (en) 2007-07-16 2009-01-22 Med-I-Dynamix Fluid Monitoring Ltd. Systems and methods for removal of urine
US20090043184A1 (en) 2007-08-08 2009-02-12 Edwards Lifesciences Corporation Catheter and probe for measuring analytes or other parameters
FR2920087B1 (en) * 2007-08-24 2009-10-23 Univ Grenoble 1 DEVICE FOR PREVENTING URINARY LEAKS
US9308307B2 (en) * 2007-09-13 2016-04-12 Fresenius Medical Care Holdings, Inc. Manifold diaphragms
US20090149776A1 (en) 2007-12-05 2009-06-11 Adams Scott C Optical sensor for detecting infection and other anomalous conditions associated with catheter systems
US8162922B2 (en) * 2008-05-07 2012-04-24 Sacco John S CUI-tagged catheter devices and system
US8114063B2 (en) * 2008-05-07 2012-02-14 Sacco John J RFID-tagged urinary catheter
US20090287170A1 (en) * 2008-05-13 2009-11-19 Preferred Medical Devices, Inc. Urine collection system
CA2953011A1 (en) 2008-05-16 2009-11-19 Maurice Garcia Catheter drainage system
NO328037B1 (en) 2008-05-22 2009-11-23 Knut Inge Bonvik System for real-time long-term regulation and / or real-time spectroscopy of a given amount of urine in patients
US8721632B2 (en) 2008-09-09 2014-05-13 Tsunami Medtech, Llc Methods for delivering energy into a target tissue of a body
US8192368B2 (en) 2008-06-09 2012-06-05 Gentera Holdings, Llc Pressure sensing catheter
US20090308588A1 (en) 2008-06-16 2009-12-17 Halliburton Energy Services, Inc. Method and Apparatus for Exposing a Servicing Apparatus to Multiple Formation Zones
US8953159B2 (en) 2008-10-03 2015-02-10 The Board Of Trustees Of The University Of Illinois Surface enhanced raman spectroscopy nanodome biosensors and methods of manufacturing the same
JP2012510877A (en) 2008-12-04 2012-05-17 ザ クリーブランド クリニック ファウンデーション System and method for defining a target volume for brain stimulation
WO2010075446A1 (en) * 2008-12-23 2010-07-01 Soar Biodynamics, Ltd. Methods and systems for prostate health monitoring
US9126854B2 (en) * 2009-02-11 2015-09-08 Clear River Enviro, Llc Apparatus for target compound treatment
DE102009017033A1 (en) 2009-04-09 2010-10-21 Pulsion Medical Systems Ag Bladder catheter for measuring the pressure in the bladder of a living being
US20110118555A1 (en) 2009-04-29 2011-05-19 Abhijit Dhumne System and methods for screening, treating, and monitoring psychological conditions
US9039655B2 (en) * 2009-11-06 2015-05-26 Crisi Medical Systems, Inc. Medication injection site and data collection system
US8801684B2 (en) 2010-02-16 2014-08-12 Medela Holding Ag Coupling part of a drainage tube unit
US7947001B1 (en) 2010-06-07 2011-05-24 Sarvazyan Armen P Methods and devices for measuring structural and elastic properties of a hollow organ
US20130218106A1 (en) 2010-07-30 2013-08-22 C. R. Bard, Inc. Automated Method of Pooling Elimination with a Biological Fluid Collection System
US9962516B2 (en) 2010-09-09 2018-05-08 University Of Florida Research Foundation, Incorporated Context-sensitive flow interrupter and drainage outflow optimization system
JP6325440B2 (en) 2011-06-23 2018-05-16 メデラ ホールディング アーゲー System for aspirating fluids from the body by means of negative pressure
JP6436402B6 (en) 2013-06-27 2019-01-30 セラノーヴァ,エルエルシー Sensing Foley catheter
WO2015105916A1 (en) 2014-01-07 2015-07-16 Consano, Inc. Systems, devices and methods for draining and analyzing bodily fluids
US11771354B2 (en) 2014-06-12 2023-10-03 Konstantin Kostov Device and method for monitoring irregular liquid flow rates
US20150362351A1 (en) 2014-06-12 2015-12-17 Jay Joshi Fluid output measurement device and method
EP3197349B1 (en) * 2014-09-28 2023-07-19 Potrero Medical, Inc. Systems, devices and methods for sensing physiologic data and draining and analyzing bodily fluids
EP3206582B1 (en) * 2014-12-22 2023-08-02 Renalsense Ltd. Apparatus, system, and methods for urinalysis
GB201513208D0 (en) * 2015-07-27 2015-09-09 Univ Central Lancashire Methods and apparatuses for estimating bladder status
EP3331445B1 (en) * 2015-08-05 2019-10-23 ART Healthcare Ltd. Point of care urine analyzer
US20170119300A1 (en) * 2015-10-29 2017-05-04 Patrona Medical, Inc. Sensor Management And Record Tracking System
TWI592596B (en) 2015-11-13 2017-07-21 Faucet water saving device and method using the water saving device
US10391275B2 (en) * 2015-11-17 2019-08-27 Potrero Medical, Inc. Systems, devices and methods for draining and analyzing bodily fluids
WO2017173342A1 (en) * 2016-03-31 2017-10-05 William Beaumont Hospital Methods for detecting, diagnosing and treating ulcerative interstitial cystitis
EP4159113B1 (en) * 2016-06-10 2024-02-28 TERUMO Kabushiki Kaisha Oxygen measurement device
US10881774B2 (en) * 2016-09-23 2021-01-05 Plc Medical Systems, Inc. Method and system to protect kidneys during surgery
EP3548133A4 (en) * 2017-01-19 2020-09-09 Potrero Medical, Inc. Systems, devices and methods for draining and analyzing bodily fluids
US11166676B2 (en) * 2017-12-11 2021-11-09 Marina I. Adrianzen Fonseca Real-time kidney monitoring medical device
GB2576043B (en) * 2018-08-03 2023-04-19 Medisyne Ltd Healthcare monitoring system

Patent Citations (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3326207A (en) 1964-07-10 1967-06-20 James J Egan Electrocardiac instrument for testing unborn infants
US4077394A (en) 1976-08-25 1978-03-07 Mccurdy Martin D Integral pressure sensor probe for a cardiac assistance device
US4502490A (en) 1980-10-28 1985-03-05 Antec Systems Limited Patient monitoring equipment, probe for use therewith, and method of measuring anesthesia based on oesophagal contractions
US4600015A (en) 1980-10-28 1986-07-15 Antec Systems Limited Patient monitoring apparatus and method
US4413633A (en) 1981-06-01 1983-11-08 Yanda Roman L Method and apparatus for monitoring body conditions
US4712566A (en) 1985-01-10 1987-12-15 Radisensor Ab Device for recording physiological pressures
US4841981A (en) 1986-03-07 1989-06-27 Terumo Corporation Catheters for measurement of cardiac output and blood flow velocity
US5035231A (en) 1987-04-27 1991-07-30 Olympus Optical Co., Ltd. Endoscope apparatus
US5220927A (en) 1988-07-28 1993-06-22 Bsd Medical Corporation Urethral inserted applicator for prostate hyperthermia
US5344435A (en) 1988-07-28 1994-09-06 Bsd Medical Corporation Urethral inserted applicator prostate hyperthermia
US5048532A (en) 1989-09-18 1991-09-17 State University Of New York Method and apparatus for measuring blood pressure
US5570671A (en) 1989-09-18 1996-11-05 The Research Foundation Of State University Of New York Method for positioning esophageal catheter for determining pressures associated with the left atrium
US5263485A (en) 1989-09-18 1993-11-23 The Research Foundation Of State University Of New York Combination esophageal catheter for the measurement of atrial pressure
US5921935A (en) 1989-09-18 1999-07-13 The Research Foundation Of State University Of New York Method and apparatus utilizing heart sounds for determining pressures associated with the left atrium
US5398692A (en) 1989-09-18 1995-03-21 The Research Foundation Of State University Of New York Combination esophageal catheter for the measurement of atrial pressure
US5158529A (en) 1990-03-29 1992-10-27 Aisin Seiki Kabushiki Kaisha Pumping device for operating an intra-aortic balloon
US5133358A (en) 1990-09-07 1992-07-28 Becton, Dickinson And Company Apparatus for rezeroing an in vivo pressure sensor and method for rezeroing
US5171299A (en) 1991-08-02 1992-12-15 Baxter International Inc. Balloon catheter inflation pressure and diameter display apparatus and method
US5413558A (en) 1991-09-09 1995-05-09 New York University Selective aortic perfusion system for use during CPR
US5257630A (en) 1992-05-15 1993-11-02 Thermometrics, Inc. Pressure sensing probe with calibration capability
US5240675A (en) 1992-09-24 1993-08-31 Wilk Peter J Method for cleaning endoscope
US5431628A (en) 1992-09-29 1995-07-11 Millar Instruments, Inc. Pressure-sensing diagnostic catheter
US5433216A (en) 1993-06-14 1995-07-18 Mountpelier Investments, S.A. Intra-abdominal pressure measurement apparatus and method
US5425362A (en) 1993-07-30 1995-06-20 Criticare Fetal sensor device
US5427114A (en) 1993-08-19 1995-06-27 Fiberoptic Sensor Technologies, Inc. Dual pressure sensing catheter
US5517998A (en) 1994-01-24 1996-05-21 Medamicus, Inc. Closed loop pressure determination system and method for fiber optic pressure transducer system
US5389217A (en) 1994-04-28 1995-02-14 Biomedical Sensors Ltd. Measurement of bladder oxygen
US5652570A (en) * 1994-05-19 1997-07-29 Lepkofker; Robert Individual location system
US5573007A (en) 1994-08-08 1996-11-12 Innerspace, Inc. Gas column pressure monitoring catheters
US5678570A (en) 1995-04-14 1997-10-21 The University Of North Carolina At Chapel Hill Method of treating cardiac arrest
US5788642A (en) 1995-06-19 1998-08-04 Becton, Dickinson And Company In vivo rezero apparatus for a pressure transducer
US6083215A (en) 1995-07-17 2000-07-04 Milavetz; James J. Method and apparatus for antegrade coronary perfusion
US5865801A (en) 1995-07-18 1999-02-02 Houser; Russell A. Multiple compartmented balloon catheter with external pressure sensing
US5984879A (en) 1996-09-03 1999-11-16 Clinical Innovation Associates, Inc. Intrauterine pressure catheter device
US6002982A (en) * 1996-11-01 1999-12-14 Fry; William R. Sports computer with GPS receiver and performance tracking capabilities
US5902248A (en) 1996-11-06 1999-05-11 Millar Instruments, Inc. Reduced size catheter tip measurement device
US6001600A (en) 1996-12-20 1999-12-14 Smithkline Beecham Plc DNA encoding tests polypeptides
US5916153A (en) 1997-10-27 1999-06-29 Rhea, Jr.; W. Gardner Multifunction catheter
US6299583B1 (en) 1998-03-17 2001-10-09 Cardiox Corporation Monitoring total circulating blood volume and cardiac output
US20020066458A1 (en) 1998-04-21 2002-06-06 Aliberto Anthony C. Central venous catheter with heat exchange membrane
US6511412B1 (en) 1998-09-30 2003-01-28 L. Vad Technology, Inc. Cardivascular support control system
US20010020162A1 (en) 1998-10-19 2001-09-06 Brian Mosel Urinary incontinence diagnostic system
US20020049425A1 (en) 1998-10-19 2002-04-25 Brian J. Mosel Urinary incontinence diagnostic system
US6149578A (en) 1999-02-04 2000-11-21 My-Tech, Inc. Piston-action intra-aortic coronary assist device
US20010035046A1 (en) 1999-06-24 2001-11-01 Jonathan Williams Balloon catheter leak detection method and apparatus
US6287253B1 (en) 1999-06-25 2001-09-11 Sabolich Research & Development Pressure ulcer condition sensing and monitoring
US20010049470A1 (en) * 2000-01-19 2001-12-06 Mault James R. Diet and activity monitoring device
US6447462B1 (en) 2000-02-15 2002-09-10 Clinical Innovation Associates, Inc. Urodynamic catheter and methods of fabrication and use
US6322514B1 (en) 2000-03-13 2001-11-27 Instrumentarium Corporation Method for determining cardiac characteristics of subject
US6918924B2 (en) 2000-04-06 2005-07-19 Innercool Therapies, Inc. Method and apparatus for regulating patient temperature by irrigating the bladder with a fluid
US6434418B1 (en) 2000-04-12 2002-08-13 Randall H. Neal Apparatus for measuring intrauterine pressure and fetal heart rate and method for using same
US6646906B2 (en) 2000-08-31 2003-11-11 Micron Technology, Inc. Methods of reading ferroelectric memory cells
US6616597B2 (en) 2000-12-12 2003-09-09 Datascope Investment Corp. Intra-aortic balloon catheter having a dual sensor pressure sensing system
US20030114835A1 (en) 2000-12-15 2003-06-19 Alsius Corporation Temperature sensor adapter for Foley catheters
US6602243B2 (en) 2000-12-15 2003-08-05 Alsius Corporation Foley catheter having redundant temperature sensors and method
US20020077680A1 (en) 2000-12-15 2002-06-20 Alsius Temperature sensor adapter for foley catheters
US20040236395A1 (en) 2001-02-09 2004-11-25 Medtronic, Inc. System and method for placing an implantable medical device within a body
US20060178571A1 (en) 2001-06-01 2006-08-10 Diametrics Medical Limited Apparatus and method for determining organ perfusion
US6997884B2 (en) 2001-06-29 2006-02-14 Ethicon, Inc. System and method for assessing urinary function
US7004899B2 (en) 2001-06-29 2006-02-28 Ethicon, Inc. System and method for assessing urinary function
US7255673B2 (en) 2001-06-29 2007-08-14 Ethicon, Inc. System and method for assessing urinary function
US7252631B2 (en) 2001-06-29 2007-08-07 Ethicon, Inc. System and method for assessing detrusor instability
US6916283B2 (en) 2001-06-29 2005-07-12 Ethicon, Inc. System and method for assessing urinary function
US7052452B2 (en) 2001-06-29 2006-05-30 Ethicon, Inc. System and method for assessing urinary function
US6666828B2 (en) 2001-06-29 2003-12-23 Medtronic, Inc. Catheter system having disposable balloon
US6912416B2 (en) 2001-07-18 2005-06-28 Peter L. Rosenblatt Detecting or preventing tissue damage
US6931276B2 (en) 2002-04-29 2005-08-16 Tomi Streng Method and device for use in micturition studies
US20040097813A1 (en) 2002-11-19 2004-05-20 Jonathan Williams Method and device for correcting in -vivo sensor drift
US7025718B2 (en) 2002-11-19 2006-04-11 Jonathan Williams Method and device for correcting in-vivo sensor drift
US20040116782A1 (en) * 2002-12-17 2004-06-17 International Business Machines Corporation Behavior based life support with abstract behavior patterns
US7154398B2 (en) * 2003-01-06 2006-12-26 Chen Thomas C H Wireless communication and global location enabled intelligent health monitoring system
US20060116601A1 (en) 2003-02-17 2006-06-01 Raymond Glocker Methods and apparatus for measuring pressure profiles
US20060234383A1 (en) 2003-02-19 2006-10-19 Nigel Gough Tissue assessment
US20040167415A1 (en) 2003-02-24 2004-08-26 Plc Systems Inc. Method and system for prevention of radiocontrast nephropathy
US7112177B2 (en) 2003-03-04 2006-09-26 Wolfe Tory Medical, Inc. Apparatus for monitoring intra-abdominal pressure
US20070038143A1 (en) 2003-03-04 2007-02-15 Christensen Mark A Medical valve and method to monitor intra-abdominal pressure
US7644722B2 (en) 2003-03-04 2010-01-12 Wolfe Tory Medical, Inc. Medical valve and method to monitor intra-abdominal pressure
US7726328B2 (en) 2003-03-04 2010-06-01 Wolfe Tory Medical, Inc. Medical valve and method to monitor intra-abdominal pressure
US7892181B2 (en) 2003-03-04 2011-02-22 AbViser Medical LLC Apparatus for monitoring intra-abdominal pressure
US7381190B2 (en) 2003-03-10 2008-06-03 Wolfe Tory Medical, Inc. Intra-abdominal pressure monitoring urinary catheter
US20060275907A1 (en) 2003-05-09 2006-12-07 Cgs Sensortechnik Gmbh Device for measuring pressure
US20050075531A1 (en) 2003-10-07 2005-04-07 Loeb Marvin P. Devices and methods for non-invasively improving blood circulation
US20060284732A1 (en) * 2003-10-23 2006-12-21 George Brock-Fisher Heart monitor with remote alarm capability
US20050148828A1 (en) * 2003-12-30 2005-07-07 Kimberly-Clark Worldwide, Inc. RFID system and method for tracking environmental data
US20070270699A1 (en) 2004-01-08 2007-11-22 Dialog Devices Limited System or Method for Assessing a Subject's Peripheral Blood Circulation
US20070255167A1 (en) 2004-03-01 2007-11-01 Wolfe Tory Medical, Inc. Apparatus for monitoring intra-abdominal pressure
US20050209524A1 (en) 2004-03-10 2005-09-22 General Electric Company System and method for receiving and storing information pertaining to a patient
US20070225584A1 (en) 2004-04-19 2007-09-27 University Of Florida Researouchfoundation, Inc. Novel Catheter Sensor
US20060100743A1 (en) 2004-04-23 2006-05-11 Renal Diagnostic Inc. Automated non-invasive real-time acute renal failure detection system
US20050288603A1 (en) 2004-06-24 2005-12-29 Goping Ing H F Method for obtaining and displaying urethral pressure profiles
US8052671B2 (en) 2004-10-11 2011-11-08 Abviser Medical, Llc Intra-abdominal pressure monitoring device and method
US20060122864A1 (en) * 2004-12-02 2006-06-08 Gottesman Janell M Patient management network
US20080103408A1 (en) 2004-12-03 2008-05-01 Wolfe Tory Medical, Inc. Continuous Intra-Abdominal Pressure Monitoring Urinary Catheter With Optional Core Temperature Sensor
WO2006060248A2 (en) 2004-12-03 2006-06-08 Wolfe Tory Medical, Inc. Pressure and temperature monitoring balloon catheter
US20110144423A1 (en) 2005-05-20 2011-06-16 Neotract, Inc. Median Lobe Retraction Apparatus and Method
US20060287604A1 (en) 2005-06-17 2006-12-21 Hickey Donald D Method of determining cardiac indicators
US7527599B2 (en) 2005-06-17 2009-05-05 The Research Foundation Of State University Of New York Method of determining cardiac indicators
WO2007018963A2 (en) 2005-07-14 2007-02-15 C.R. Bard, Inc. Intra-abdominal pressure monitoring system
US8337411B2 (en) 2005-07-14 2012-12-25 C. R. Bard, Inc. Intra-abdominal pressure monitoring system
US20090221933A1 (en) 2005-07-14 2009-09-03 C.R. Bard, Inc. Intra-abdominal pressure monitoring system
US20070083126A1 (en) 2005-09-27 2007-04-12 Angiometrx, Inc. Apparatus & method for determining physiologic characteristics of body lumens
US20110040211A1 (en) 2005-10-18 2011-02-17 Pneumoflex Systems, Llc Oral-esophageal-gastric device to diagnose reflux and/or emesis
US20110046653A1 (en) 2005-10-18 2011-02-24 PNEUMOFLEX SYSTEMS, LLC, State of Incorporation: Florida Oral-esophageal-gastric device with esophageal cuff to reduce gastric reflux and/or emesis
US20100228148A1 (en) 2005-11-15 2010-09-09 Kyoung-Hun Kim Novel Quantitative and Qualitative Analysis Apparatus for Measuring the Body Fluid
US20090312740A1 (en) 2005-12-27 2009-12-17 Acist Medical Systems, Inc. Balloon Inflation Device
US20070197881A1 (en) * 2006-02-22 2007-08-23 Wolf James L Wireless Health Monitor Device and System with Cognition
US20070219823A1 (en) * 2006-03-17 2007-09-20 Warner Adrian F Patient monitoring device for remote patient monitoring
US20100286559A1 (en) 2006-08-23 2010-11-11 Ilan Paz Diagnostic methods and systems based on urine analysis
US20080076971A1 (en) * 2006-08-31 2008-03-27 Geoffrey Clapp Health related location awareness
US20080140000A1 (en) 2006-12-07 2008-06-12 Cardiac Pacemakers, Inc. Device and method for modulating renal function
US20080164998A1 (en) * 2007-01-05 2008-07-10 Siemens Medical Solutions Usa, Inc. Location Sensitive Healthcare Task Management System
WO2008097609A2 (en) 2007-02-07 2008-08-14 Massachusetts Institute Of Technology Methods and devices for sensing tissues and tissue compartments
US20100121220A1 (en) 2007-02-21 2010-05-13 C. R. Bard, Inc Renal monitor
US8403884B2 (en) 2007-02-21 2013-03-26 C. R. Bard, Inc. ACS therapy system
WO2008103625A2 (en) 2007-02-21 2008-08-28 C.R. Bard, Inc. Acs therapy system
US8366639B2 (en) 2007-03-26 2013-02-05 Jms Co., Ltd. Balloon for measuring pressure related to oral cavity and method for producing the same
WO2008117574A1 (en) 2007-03-26 2008-10-02 Jms Co., Ltd. Balloon for measuring pressure related to oral cavity and method for producing the same
US20080262418A1 (en) 2007-04-05 2008-10-23 Daniel Rogers Burnett Automated Therapy System and Method
US20100130880A1 (en) 2007-04-16 2010-05-27 Urodynamix Technologies Ltd. Apparatus and methods for monitoring blood flow in the prostrate gland
US8075499B2 (en) * 2007-05-18 2011-12-13 Vaidhi Nathan Abnormal motion detector and monitor
US20090076573A1 (en) 2007-07-09 2009-03-19 Daniel Rogers Burnett Hypothermia Devices and Methods
US8301575B2 (en) * 2007-07-23 2012-10-30 Commissariat A L'energie Atomique Method and device for the recognition of the position or movement of a device or a person
US20090062686A1 (en) * 2007-09-05 2009-03-05 Hyde Roderick A Physiological condition measuring device
US20100249663A1 (en) 2007-10-23 2010-09-30 C.R. Bard, Inc. Continuous intra-abdominal pressure monitoring system
WO2009055435A1 (en) 2007-10-23 2009-04-30 C. R. Bard, Inc. Continuous intra-abdominal pressure monitoring system
US20090120439A1 (en) 2007-11-08 2009-05-14 Fred Goebel Method of triggering a ventilator
US8116838B2 (en) 2007-11-27 2012-02-14 Carnegie Mellon University Medical device for diagnosing pressure ulcers
US20100049095A1 (en) * 2008-03-14 2010-02-25 Stresscam Operations & Systems, Ltd. (c/o PHD Associates) Assessment of medical conditions by determining mobility
US20090306588A1 (en) 2008-06-06 2009-12-10 Ethicon, Inc. Balloon catheter systems and methods for treating uterine disorders
US20100030190A1 (en) 2008-06-24 2010-02-04 Singh Vijay P Gastroduodenal balloon tubes and methods for use in localized hypothermia
US20100010552A1 (en) 2008-07-10 2010-01-14 Texas Heart Institute Method and system for temperature analysis to provide an early marker of congestive heart failure progress that precedes a patient's symptoms
US20110133927A1 (en) * 2008-08-14 2011-06-09 Humphrey Christopher A Environmental risk management system and method
US20100056872A1 (en) * 2008-08-29 2010-03-04 Philippe Kahn Sensor Fusion for Activity Identification
US20100057046A1 (en) 2008-09-03 2010-03-04 Keimar, Inc Systems for characterizing physiologic parameters and methods for use therewith
US20100121159A1 (en) 2008-11-07 2010-05-13 Daniel Rogers Burnett Devices and Methods for Monitoring Core Temperature and an Intraperitoneal Parameter
US8979774B2 (en) * 2009-01-13 2015-03-17 Robert Bosch Gmbh Activity monitoring device and method
US20110071482A1 (en) 2009-01-28 2011-03-24 Selevan James R Devices and methods for signaling when action is due in relation to a medical device
US20100204765A1 (en) 2009-02-06 2010-08-12 Hall Gregory W Method and Apparatus for Inducing Therapeutic Hypothermia
US20100234693A1 (en) * 2009-03-16 2010-09-16 Robert Bosch Gmbh Activity monitoring device and method
US8396537B2 (en) 2009-04-20 2013-03-12 Mindray Ds Usa, Inc. Method and system to measure ECG and respiration
US20110082554A1 (en) 2009-10-02 2011-04-07 Glazer Paul A Devices for delivering spinal disc implants
US20110184247A1 (en) * 2010-01-25 2011-07-28 Contant Olivier M Comprehensive management of human health
US20120095537A1 (en) 2010-02-08 2012-04-19 Hall Gregory W Method and Apparatus for Inducing Therapeutic Hypothermia
US20130231584A1 (en) 2010-07-09 2013-09-05 Daniel Rogers Burnett Method and apparatus for pressure measurement
US20120029390A1 (en) * 2010-07-30 2012-02-02 John Colborn Seizure detection using coordinate data
US9507027B2 (en) * 2010-08-06 2016-11-29 Qualcomm Incorporated Determining location of a target device based on relative change in location information
US20130030262A1 (en) 2011-03-07 2013-01-31 Theranova, Llc Sensing foley catheter
US20130066166A1 (en) 2011-03-07 2013-03-14 Theranova, Llc Sensing foley catheter
WO2012122267A1 (en) 2011-03-07 2012-09-13 Theranova, Llc Sensing foley catheter
EP2683422A1 (en) 2011-03-07 2014-01-15 Theranova, LLC Sensing foley catheter
US9655555B2 (en) 2011-03-07 2017-05-23 Potrero Medical, Inc. Sensing foley catheter
US9662058B2 (en) 2011-03-07 2017-05-30 Potrero Medical, Inc. Sensing Foley catheter

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Addington et al., Intra-abdominal Pressures during Voluntary and Reflex Cough, BioMed Central Cough 2008, 4:2, Apr. 30, 2008.
Balogh et al., Continuous intra-abdominal pressure measurement technique. The American Journal of Surgery 188 (2004) 679-684.
Marquet Getinge Group, Background of Zeroing/Calibration Process of a Pressure Measurement Device, 2010.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11963773B2 (en) 2011-03-07 2024-04-23 Theranova, Llc Method of monitoring health status of a patient

Also Published As

Publication number Publication date
US20130030262A1 (en) 2013-01-31
EP2683422A1 (en) 2014-01-15
US20170332955A1 (en) 2017-11-23
US20240215884A1 (en) 2024-07-04
US9662058B2 (en) 2017-05-30
US20130066166A1 (en) 2013-03-14
EP3524282A1 (en) 2019-08-14
WO2012122267A8 (en) 2012-11-15
US20170100561A1 (en) 2017-04-13
US20210177330A1 (en) 2021-06-17
US10952659B2 (en) 2021-03-23
US11883174B2 (en) 2024-01-30
US11963773B2 (en) 2024-04-23
EP2683422A4 (en) 2014-08-20
US20220095978A1 (en) 2022-03-31
US9655555B2 (en) 2017-05-23
EP2683422B1 (en) 2019-05-08
WO2012122267A1 (en) 2012-09-13

Similar Documents

Publication Publication Date Title
US11963773B2 (en) Method of monitoring health status of a patient
AU2019203634B2 (en) Sensing Foley catheter
AU2020256358B2 (en) Systems, devices and methods for sensing physiologic data and draining and analyzing bodily fluids
WO2014043650A2 (en) Systems, devices and methods for urine monitoring

Legal Events

Date Code Title Description
AS Assignment

Owner name: THERANOVA, LLC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BURNETT, DANIEL R.;REEL/FRAME:040106/0496

Effective date: 20160318

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE